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Summary
Bax is a pro-apoptotic Bcl-2 family member that experiences a net translo-
cation from the cytosol to mitochondria under cell stress. It inserts and
oligomerizes irreversibly in the mitochondrial outer membrane (MOM) to
mediate its permeabilization, leading to cytochrome c release and cell death.
Bax translocation also correlates with massive mitochondrial fragmentation.
Indeed, Bax colocalizes with the dynamin-related protein 1 (Drp1) at fission
sites during apoptosis. However, the molecular basis behind Bax function
and the nature of Bax structures responsible for MOM permeabilization
remain poorly understood.
In this thesis, we studied the nanoscale spatial organization of Bax at
mitochondria of apoptotic cells using dual-color super-resolution microscopy.
We also investigated Bax interplay with Drp1 at the single-molecule level by
fluorescence cross-correlation spectroscopy (FCCS).
We show that active Bax assembled into distinct architectures including
full rings, arcs, and lines that localized in discrete foci along mitochondria
in close association with Drp1 foci. The physiological relevance of these
structures is supported by the different organization adopted by an inactive
mutant that constitutively localizes at the MOM. Remarkably, both rings
and arc-shaped oligomeric assemblies of Bax perforated the membrane, as
revealed by atomic force microscopy in lipid bilayers.
Moreover, in vitro FCCS assays with recombinant proteins in single-vesicle
approaches threw light upon the interaction between Bax and Drp1, where
the membrane environment has an active contribution.
Our data identify the supramolecular organization of Bax during apoptosis
and support a molecular mechanism in which Bax fully or partially delineates
pores of different sizes to permeabilize the MOM. Altogether, our results
contribute to the understanding of the interplay between the mitochondrial
fission machinery and cell death regulation.
Zusammenfassung
Bax ist ein pro-apoptotisches Mitglied der Bcl-2 Proteinfamilie, das während
Zellstress vom Cytosol zur den Mitochondrien bewegt. Bax dringt in die
mitochondrialen Außenmenbran ein. Durch Oligomerisierung bildet es Poren
durch die Cyt c entweicht, was letztlich zum Zelltod führt. Die Translokation
von Bax korreliert auch mit der massiven Fragmentierung von Mitochondrien.
Zusätzlich kolokalisiert Bax mit dem Dynamin-verwandten Protein 1 (Drp1)
an den Teilungsregion der Mitochondrien während Apoptose. Allerdings sind
die molekularen Grundlagen der Funktion von Bax sowie die strukturelle
Anordnung dieses Proteins bei der Membran-Permeabilisierung weitgehend
unbekannt.
In der vorliegenden Arbeit haben wir die Nano-Anordnung von Bax in
apoptotischen Mitochondrien mit zweifarbigen hochauflösenden Mikroskopie
ermittelt. Weiter haben wir auch das Zusammenspiel zwischen Bax und
Drp1 auf Einzelmolekülebene mit Hilfe von Fluoreszenz-Kreuzkorrelations-
Spektroskopie (FCCS) untersucht.
Unser Ergebnis zeigt, dass aktives Bax Ringe, unvollständige Ringe, Bö-
gen und Linien entlang der Mitochondrien in enger Verbingung mit Drp1
ausbildet. Die physiologische Bedeutung dieser Strukturen wird von einer
inaktiven, konstitutiv Membran-gebundenen Mutante von Bax unterstützt,
die nicht dieselben Anordnungen an der Membran zeigt. Bemerkenswert
hierbei ist, dass sowohl volle als auch unvollständige Ringe die Membran
durchlöcherten, wie Atomkraftmikroskopie mit Lipiddoppelschichten zeigte.
Außerdem, gaben in vitro FCCS Untersuchungen einen Einblick in das
Bax-Drp1 Zusammenspiel, wobei die Membranumgebung einen essentiellen
Beitrag leistet.
Unsere Studien haben den supramolekularen Aufbau von Bax während
der Apoptose aufgeklärt. Hierbei unterstützen die Daten einen molekularen
Mechanismus bei dem Bax gänzlich oder teilweise Poren unterschiedlicher
Größe ausbildet um die mitochondriale Außenmembran zu permeabilisieren.
Zussamenfassend trägt diese Arbeit zu unserem Verständis des Zusammen-
spiels zwischen mitochondrieller Dynamik und programmiertem Zelltod
bei.
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1Programmed cell death
Billions of cells die in our body every day, but when can we state that a cell is
dying, or really dead? These concepts have kept researchers busy for the last
decades and many definitions and nomenclatures concerning a cell’s life path
have been published. In 2009, The Nomenclature Committee on Cell Death
(NCCD) collected this hodgepodge of terminologies and agreed on a universal
criteria for the definition of cell death characteristics and morphology, which
is continuously updated. According to the NCCD, there is an irreversible
point that a cell reaches in the dying process. Depending on the type of cell
death, this step can be characterized by: externalization of phospatidylserine,
extensive caspase activation, loss of mitochondrial membrane potential, or
permeabilization of the mitochondrial outer membrane (MOM). If the cell
loses the plasma membrane integrity, it is fragmented into bodies and these
fragments are eaten by the neighboring cells, then death can be confirmed
(Kroemer et al., 2009).
It was not until 1965 when the term “programmed cell-death” (PCD) was
officially used to define a controlled, intracellular, self-destruction process
observed in insect cells during their development (Lockshin and Williams,
1965). Some years later, “apoptosis” came onto the scene to name a specific
type of programmed cell death with conserved morphological features (Kerr
et al., 1972). While this is the most acclaimed form, additional types of
programmed cell death with unique phenotypes and biochemical characteris-
tics have arisen, including autophagy, necroptosis, cornification and other
minor types. In this chapter, I will introduce the different PCD types and
comment on their differences and similarities, and then focus on apoptosis.
1.1. Apoptosis
Although it may sound illogical, the destruction of cells is as essential as
their creation in the course of proper formation, growth and development
of multi-cellular organisms. Most of the cells bring about their demise
through apoptosis (from the Greek, “fall off”). Far from being random,
this process is deliberately controlled and programmed, following a specific
hierarchy of molecular events. The term was first coined by J Kerr and
colleagues (Kerr et al., 1972) and ever since, scientists have worked tirelessly
to deeply understand the significance, regulation and mechanisms behind
this transcendent process. It has long been known that the size and shape
of some tissues are determined by a coordination of cell death patterns. Our
webbed limbs give rise to separate fingers and toes when cells between them
13
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Apoptosis
Necrosis
Necroptosis
Figure 1.1. Programmed cell death morphology. Cell shape transforma-
tion after induction of different types of cell death. Left panels show healthy cells
and middle and right panels show sequential induction times.
die (Zakeri et al., 1994) and programmed cell death also sculpts other organs
such as the intestine or the palate (Cuervo and Covarrubias, 2004). During
the development of the nervous system, cells that are not needed for proper
synaptic connections have to be removed (Kim and Sun, 2011). Besides
characterizing tissue and organ morphogenesis, apoptosis helps to maintain
cellular homeostasis, for instance, by killing cells of the uterine wall during
menstruation (Li et al., 2005). Moreover, cells also kill themselves off when
they sense a potential threat to the organism, such as a virus infection or
DNA damage (Hardwick, 2001).
In order to function correctly, adult tissues need a perfect balance between
cell proliferation and death, and apoptosis mismanagement can carry fatal
consequences. Excessive cell death causes tissue damage and is associated
with the occurrence of strokes, heart attacks or diseases such as Alzheimer’s
and Parkinson’s (Su et al., 1994; Lev et al., 2003). On the other hand, if not
enough cells die, then their massive accumulation in some organs can lead
to a reaction against the organism’s own cells, causing autoimmune diseases.
The lack of apoptosis is also linked to tumor growth because cancer cells can
escape the cell death signals and grow excessively, responding ineffectively
to anti-cancer therapies (Vaux et al., 1988; Tsujimoto et al., 1984).
Apart from being essential to human development, apoptosis differs from
other cell death types in the events that trigger it and in the morphological
transformations that it generates. Apoptotic cells die in a rather “clean”
way, without leaving a trace or awakening any inflammatory response. The
apoptotic phenotype is characterized by cell shrinkage and overall round
shape, chromatin condensation, organelle packing and plasma membrane
blebbing. These blebs ultimately separate from the cell forming membrane-
14
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enclosed apoptotic bodies which are rapidly eaten up by the neighboring
cells or by macrophages (Fig. 1.1).
The main actors of apoptosis comprise a large set of proteins located in
different cell compartments contributing to the process in a regulatory, recep-
tive, adaptive or executioner manner. The discovery of the Bcl-2 mammalian
gene laid the foundation to understand the apoptotic machinery, followed by
the constitution of the Bcl-2 family of proteins, which are the key orchestra-
tors of apoptosis. A family of cystein proteases known as caspases coordinate
to dismantle the cell and act exclusively in the apoptotic play. They are com-
monly classified according to their function as initiators (caspase-2,-8,-9,-10),
executioners (caspase-3,-6,-7) and inflammatory caspases (caspase-1,-4,-5).
Caspases are first synthesized as inactive zymogens and become activated
after diverse death signaling events, generating an activation cascade that
allows the final controlled demolition of the cellular components(Kischkel,
F.C., S Hellbardt, I Behrmann, M Germer, M Pawlita, P H Krammer, 1995).
In addition, many induced transcription factors (ITFs), apoptogenic factors
such as cytochrome c (cyt c), receptors of the tumor necrosis factor (TNF)
family or particular lipids have a remarkable role in supporting the apoptotic
scenario. Therefore, it is to be noted that the term apoptosis defines precise
phenotypes and biochemical characteristics and should not be used as a
mere synonym for programmed cell death.
1.2. Programmed necrosis
In contrast to apoptosis, necrosis leaves a more “chaotic” scenario. After
an external insult such as an infection or a cut off in the blood supply, cells
burst, swell and the intracellular components are spread to the extracellular
milleu, inducing inflammation (Vandenabeele et al., 2010). Although it has
been considered as an accidental and random type of cell death for a long
time, growing evidence supports the existence of programmed necrosis, the
most common form known as necroptosis (Degterev et al., 2005).
This controlled cell death becomes activated not only after physical damage,
but also during neurodegeneration and ischemia. It was discovered as a back-
up mechanism for cell suicide after the inhibition of caspases. Necroptosis
is triggered in response to specific signal transduction pathways dependent
mainly on one kinase: RIPK1. (Degterev et al., 2005). Other downstream
kinases such as RIPK3 or the pseudo-kinase MLKL act as the executioners
of the necroptotic cascade (Sun et al., 2012; Cai et al., 2014; Cho et al.,
2009). The concept of programmed necrosis has been gaining ground with
the implication of other components such as death domain receptors (e.g.
TNFR1, Fas/CD95 and TRAIL-R), Toll-like receptors (e.g., TLR3 and
TLR4) or NADPH oxidases. Besides necroptosis, mitochondrial permeability
transition (MPT)-regulated necrosis and parthanatos, which depends on the
activation of PARP , have been described as additional types of controlled
necrosis (Jouan-Lanhouet et al., 2012). Despite the obvious discrepancies
15
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with apoptosis, both processes seem to share some common mediators, such
as some death receptors, the p53 gene and even certain Bcl-2 proteins
(Muñoz-Pinedo, 2012; Golstein and Kroemer, 2007; Whelan et al., 2012)
(Fig. 1.2).
1.3. Autophagy
Autophagy is a self-cannibalization mechanism designed for recycling long-
living proteins and damaged organelles. During this conserved catabolic
process, the cytoplasm suffers large vacuolization and the chromatin is
usually not condensed, so cells can recover until the last stages of the
process (Nikoletopoulou et al., 2013). The most studied type of autophagy
is macroautophagy, where double-membrane vesicules (autophagosomes)
surround the cytoplasmic macromolecules and other cellular components,
targeting them for lysosomal degradation by specific hydrolases (Levine
and Kroemer, 2008). Far from being just a recycle bin, autophagy can also
be promoted during normal development and differentiation but excessive
autophagy is also linked to the progression of some diseases (Ding et al.,
2006; Nikoletopoulou et al., 2013). This dual role of autophagy in cell death
and survival is therefore a matter of debate. Interestingly, a special type of
autophagy implicated in mitochondria turnover has recently emerged and
named mitophagy (Lemasters, 2005).
The crosstalk between autophagy and apoptosis is more than evident.
Both are activated in response to metabolic stress and can collaborate to
influence the cell’s fate. Indeed, the Bcl-2 family member Mcl-1 acts as a
stress sensor that coordinately controls autophagy and apoptosis (Germain
et al., 2011). Furthermore, according to some reports, the autophagic
protein Beclin-1 interacts with the anti-apoptotic proteins Bcl-2 and Bcl-xL;
although these observations are still controversial in the field (Pattingre
et al., 2005; Takacs-Vellai et al., 2005)(Fig. 1.2).
APOPTOSISNECROPTOSIS AUTOPHAGYp53
Beclin-1Bcl-2/Bcl-xL
Caspase inactivation
Nec-1
DNA
damage
Metabolic
stress
Genomic
stress
?
zVAD-fmk
Mitochondrial alterations
(ROS, Ca , ATP depletion)
2+
Survival
response?
RIPKs
Figure 1.2. Interplay between different types of programmed cell
death.
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The field of cell death has expanded tremendously and new cell death modal-
ities have been outlined including cornification, mitotic catastrophe, anoikis,
paraptosis, pyraptosis, and entosis. Cornification is seen as a particular ep-
ithelial differentation mechanism by the formation of corneocytes, which are
dead keratynocites containing proteins and lipids that provide the necessary
elasticity, stability and mechanical resitance to the skin (Candi et al., 2005).
We can refer to mitotic catastrophe when cells die as a result of defective
mitosis and experience micro- or multi-nucleation (Roninson et al., 2001).
Anoikis represents an altered form of apoptosis induction, when cells detach
from the substrate or from other cells (Grossmann, 2002). Paraptosis de-
fines a particular cell death induced by the expression of insulin-like growth
factor receptor 1. It involves cytoplasm vacuolization and mitochondrial
swelling, but it is resistant to caspase inhibition and to overexpression of
anti-apoptotic Bcl-2 proteins (Sperandio et al., 2000). Contrarily, pyroptosis
was introduced as a caspase-1 dependent process suffered by macrophages
after the infection with diverse pathogens (Fink and Cookson, 2007). Fi-
nally, entosis happens when one cell acts as a “cannibal” by engulfing a live
neighbouring cell, which dies afterwards within the phagosome (Overholtzer
et al., 2007). Regardless of the big increase in the number of publications
related to PCD, the specific characteristics of these atypical types still need
to be further elucidated.
17
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2Molecular pathways ofapoptosis
The following chapter describes the details of the apoptotic process, starting
with the leading pathways and including its intriguing regulators and the
proposed models for its activation and control, as well as its connections
with mitochondrial dynamics.
2.1. Highways to death
When a cell is committed to die via apoptosis, it can follow two main routes
depending on the signals that have triggered the stress: the extrinsic or the
intrinsic route (Fig. 2.1). The former gathers signals from the extracellular
environment, while the latter responds to intracellular signals and it is often
nicknamed as the “mitochondrial pathway”. There is an additional secondary
apoptosis pathway used by cytotoxic cells and induced via the secretion of a
granule serine-protease, granzyme B. Despite the different starting points,
these roads mostly converge at mitochondria and lead to the activation
of the same executioner caspases, sharing the last stages of the apoptotic
process (Elmore, 2007).
2.1.1. Extrinsic pathway
The extrinsic apoptotic pathway has proved vital for the correct functioning
of the immune system. In this route, the signal for suicide comes from
outside, through the ligation of surface receptors belonging mainly to the
tumor necrosis factor (TNF) superfamily (Walczak and Krammer, 2000;
Locksley et al., 2001; Fulda and Debatin, 2006). Some of the best studied
ligand-receptor couples include FasL/FasR, TNF-α/TNFR1, Apo3L/DR3,
Apo2L/DR4 and Apo2L/DR (Ashkenazi and Dixit, 1998; Rubio-Moscardo
et al., 2005). After recruiting the apoptotic ligands in the extracellular side,
the death receptors form trimers in the plasma membrane and undergo
conformational changes. This leads to their interaction with intracellular
cytoplasmatic adaptor proteins containing death domains, such as RIPK1,
FADD (Fas-associated death domain protein) and c-FLIP. As a result, the
death inducing signaling complex (DISC) is assembled, which promotes the
auto-catalytic activation of procaspase-8, a further downstream activation
of executioner caspases and ultimately cell death (Deveraux et al., 1998;
Muzio et al., 1996; Lavrik et al., 2005) (Fig. 2.1). The final steps of this
19
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route diverge according to the cell type. In type I cells (e.g.: lymphocytes),
caspase-8 or 10 can directly cleave the executioner caspases, whereas type II
cells (e.g., hepatocytes) require a detour through the mitochondrial pathway
in order to conclude the process (Li et al., 1998; Scaffidi et al., 1998).
DISC
Caspase-8/10
Caspase-3/6/7
Apoptosome
Extrinsic pathway Intrinsic pathway 
Death signals 
Cyt c
BID
BAK
BAX
BCL-2
BIM
BAD
BCL-xL
tBID
tBID
Figure 2.1. Main apoptotic pathways. In the extrinsic pathway, binding
of ligands to the death receptors triggers the formation of the complex DISC.
Activation of caspase-8 can activate BID by cleavage, which relays the death signal
to the intrinsic pathway. When BH3-only proteins are activated, they can inhibit
the anti-apoptotic Bcl-2 members and activate Bax and Bak, leading to MOMP
and cell death.
2.1.2. Intrinsic pathway
When death stimuli reach the cell internally via a non receptor-mediated
mechanism, such as radiation or oxidative stress, the intrinsic pathway of
apoptosis is triggered (Green and Kroemer, 2004). The key event of no return
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is the permeabilization of the mitochondrial outer membrane (MOMP) by
pro-apoptotic members of the Bcl-2 family of proteins. Close to reaching
this point, mitochondria experience membrane potential loss and functional
and morphological alterations, such as fission, lipid peroxidation or cristae
remodeling. Once the membrane is permeable, the so-called apoptotic factors
are released from the intermembrane space of mitochondria into the cytosol.
These include cyt c, SMAC/Diablo, Omi/HrtA2, Apoptosis Inducing Factor
(AIF) and Endonuclease G (EndG). As a consequence, the apoptosome is
formed, a multiprotein complex composed by cyt c, APAF-1 (apoptosis
protease activating factor), initiator caspase 9 and ATP. Once active, this
molecular platform can cleave caspase-9, leading in turn to further caspase-3
and -7 activation and finally to apoptotic cell death (Fig. 2.1).
2.1.3. Meeting point of apoptosis pathways at
mitochondria
Although the connection between the release of certain mitochondrial-residing
proteins in the cytosol and apoptosis progression was not established until
the late 90s, it was soon taken for granted that mitochondria constitute a
cross-road in the cell’s suicide mechanism. Once mitochondria are severly
compromised, cells will die no matter what, in a rather fast process. A
regulator member of the Bcl-2 family called Bid connects the two main
apoptotic routes (Luo et al., 1998) (see section 2.2). This pro-death protein
is not only cleaved and activated during the intrinsic pathway but also by
the active caspase-8 generated in the receptor pathway.
As mentioned earlier, mitochondria serve as a safe compartment where
apoptotic factors are kept in healthy cells but discharged in a controlled
manner after apoptotic insults. The small (12 kDa) electron carrier cyt
c is one of the components of the apoptosome and is released into the
cytosol after MOM permeabilization and oxidation of cardiolipin (CL), a
mitchondrial lipid loosely associated to the MOM (Liu et al., 1996). Two
larger proteins, SMAC/DIABLO (25 kDa) and Omi/HtrA2 (37 kDa) are
also released to facilitate caspase activation by binding and neutralizing
specific endogenous inhibitors of caspases (IAPs)(Saelens et al., 2004). AIF
(62 kDa) and EndoG (23 kDa) translocate to the nucleus after their release
and mediate chromatin condensation and DNA fragmentation (Parrish et al.,
2001; Susin et al., 1996). There are different theories about the release
order of all these proteins from the mitochondria. Some reports assume a
step-wise dispensation of cyt c, SMAC/DIABLO, and AIF (Daugas et al.,
2000; Chauhan et al., 2001) while others defend the simultaneous release
of cyt c and SMAC/DIABLO (Rehm et al., 2003; Muñoz-Pinedo et al.,
2006). One argument in favor of uncoordinated timing would be the different
confinement mechanisms of these proteins within the mitochondria. For
instance, AIF is anchored to the inner membrane and needs to be cleaved
in order to be released, while more than 85% of the cyt c is bound to CL
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on the cristae, which have to remodel before cyt c can be released. (Polster
et al., 2005; Scorrano et al., 2002). Furthermore, it is unclear if the MOM
pores can be size- and protein- selective, so that only specific factors could
pass through.
2.2. Bcl-2 family: ying and yang of cell death
2.2.1. Origin and classification
In the 1980s, studies in human follicular lymphoma identified a new gene
involved in the 14;18 chromosome translocation that was found to promote
cell survival (Tsujimoto et al., 1984; Vaux et al., 1988). This oncogene,
named B-cell lymphoma 2 (Bcl-2), was later linked to apoptosis due to its
high homology with the gene that inhibits cell death in C. Elegnans (CED-9)
(Hockenbery et al., 1990). Ever since, a long road has been paved towards
the understanding of apoptotis regulation and Bcl-2 has given rise to a well
matched family of proteins that work together to balance all the mechanisms
involved in this pathway of programmed cell death.
All the members of this family share one or more of the four conserved
Bcl-2 homology (BH) regions that determine to a big extent the proteins’
function and classification (Fig. 2.2). When the four BH regions (BH1-BH4)
are present, the Bcl-2 homologs are commonly anti-apoptotic, enclosing
Bcl-2, Bcl-w, Bcl-xL, Mcl-1, and A1. If BH4 region is absent or modified,
the proteins exhibit pro-apoptotic functions mainly due to pore forming
properties (Bax, Bak, Bok). A third group contains only the BH3 domain,
the so called BH3-only proteins, and has evolved to feel cellular stress and to
regulate the other two groups to promote apoptosis. The BH3-only members
can be further divided into sensitizers (e.g, Bad, Bmf, Bik, Noxa or Hrk),
which only interact with antiapoptotic proteins to inhibit their effect, and
direct activators (e.g: Bid, Bim, Puma), which also directly activate Bax
and Bak (García-Sáez, 2012; Shamas-Din et al., 2011). An updated database
compiling all the sequence, structural, and functional information about
Bcl-2 proteins can be found here https://bcl2db.ibcp.fr/BCL2DB/
2.2.2. Structural details
Despite their opposing functions in cell death regulation, Bcl-2 homologs
are evolutionary conserved and show high resemblance in structure and
sequence (Petros et al., 2004). These small proteins can be found in a
water-soluble, membrane-associated, or membrane-embedded conformation.
The multi-domain members of the family share a common, globular fold
consisting of a bundle of 9 or 10 α-helices. Helices 1 to 8 constitute the Bcl-2
core and the hydrophobic C-terminal helix α9 is tipically a transmembrane
domain responsible for membrane anchoring. Strikingly, the Bcl-2 core fold
is very similar to the pore-forming domain of some bacterial toxins, which
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Anti-apoptotic: Bcl-2 Bcl-xL Bcl-w Mcl-1A1/BFL1 Bcl-B
Effectors: Bak Bax Bok?
BH3-only:
Bim Bid
Bad
Puma
Bmf Hrk Noxa
Direct activators:
Sensitizers:
Figure 2.2. Bcl-2 family classification. Representation of the different Bcl-2
groups with the corresponding structural BH and transmembrane domains (TM).
can also adopt soluble and membrane structures (Muchmore et al., 1996;
Petros et al., 2004).
While there is extensive detailed information about the tridimensional
structure of Bcl-2 proteins in solution, the membrane structural knowledge
is still limited. However, this situation is slowly changing thanks to the
recent progress on this topic.
Solution
In the aqueous environment, the central hydrophobic hairpin of Bcl-2 ho-
mologs α5-α6 is surrounded by the rest of amphipatic helices of different
lengths. The domains BH1 to BH3 are in close proximity and shape a
hydrophobic cleft carved in the protein surface where the hydrophobic α9
is sequestered, rendering the protein hydrosoluble. If α9 is dispatched, this
cleft becomes the binding site for the BH3 domains of other Bcl-2 proteins
(Suzuki et al., 2000; Petros et al., 2000) (Fig. 2.3).
The first water soluble structure to be resolved was that of Bcl-xL lacking
the C-terminal domain (Muchmore et al., 1996). The rest of the anti-
apoptotic Bcl-2 members show a very similar fold, diverging mainly in the
BH3-binding groove. In general, an increase in distance between α3 and α4
is the main rearrangement produced in anti-apoptotic proteins upon BH3-
ligand binding. In the case of Bcl-xL, the plasticity of this segment enables
the interaction with PUMA and prevents the binding of p53 (Follis et al.,
2013). On the contrary, Mcl-1 shows a more loosely packed α3 and α4 helices,
favored by regions with high positive electrostatic potential flanking the
hydrophobic cleft (Day et al., 2005). Based on their BH3-binding patterns,
we can distinguish two main types of soluble structures among the Bcl-2-like
proteins, one including Bcl-xL, Bcl-w and Bcl-2 itself and the other enclosing
Mcl-1 and A1 (Dutta et al., 2010; Certo et al., 2006).
Bax is an inactive monomeric protein in solution that also displays a
central amphipathic hairpin surrounded by solvent-exposed helices. Its C-
terminal tail resembles the one of Bcl-xL and it is normally hidden within the
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surface groove preventing the binding to any potential partner (Muchmore
et al., 1996; Suzuki et al., 2000; Moldoveanu et al., 2006). Nonetheless, BH3
ligands can also interact with Bax in a non-canonical way to an alternative
cleft located in α1-α6. This association allosterically regulates the activation
and oligomerization of Bax, as well as its interactions with external partners
(Gavathiotis et al., 2008; Edwards et al., 2013; Leshchiner et al., 2013).
In turn, inactive Bak is constitutively bound to the MOM via the C-
terminal helix α9, with the helices within the Bcl-2 core in a globular fold
facing the cytosolic side. Nevertheless, studies with BH3 peptides have
revealed that in Bak unbound state, the canonical BH grove is occluded
by other means (Moldoveanu et al., 2013). Unlike Bax, Bak lacks a non-
canonical groove, so in order to be activated by homo-oligomerization and to
interact with other partners it has to adopt an open conformation making
the BH cleft available for binding (Moldoveanu et al., 2013, 2006).
BH3-only proteins are physiologically unstructured, with the exception
of Bid, which features a comparable Bcl-2 core architecture (Hinds et al.,
2007). However, they can fold in a well-ordered helix upon binding to Bcl-2
partners. Bid has a disordered region between α2 and α3 that is targeted
for cleavage by caspase 8, generating the active truncated form (tBID),
in which the BH3 domain is exposed and ready for binding (Chou et al.,
1999; McDonnell et al., 1999; Gross et al., 1999). This intrinsic disordered
region has also been observed for other Bcl-2 members. For instance, Bcl-xL
displays a flexible, unstructured loop placed between α1 and α2 that can
be targeted by caspases, turning Bcl-xL into a pro-death Bax-like protein
(Cheng et al., 1997; Basañez et al., 2001).
Figure 2.3. Structures of Bcl-2 proteins compared to the pore forming
domain of colicin. The central hairpin is shown in purple and the rest in grey.
(A) Soluble pore forming domain of colicin (PDB:). (B) Soluble form of human
Bcl-xL without the C-terminal domain (PDB:1MAZ) (Muchmore et al., 1996).
(C) Soluble form of Bax (Suzuki et al., 2000) . (D) Membrane form of Bax dimer
in a clamp conformation (Bleicken et al., 2014). (E) Bax monomer forming part
of the domain swapped dimer in complex with BidBH3 (Czabotar et al., 2013)
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Membrane
During apoptosis, Bax and Bak form big clusters in the MOM to mediate
its permeabilization. The indisputable analogy between Bcl-2 members and
the pore-forming domains of bacterial toxins supposed a big boost to the
structural understanding of the active, membrane-bound state of the killer
Bcl-2 proteins (Muchmore et al., 1996). Bacterial toxins are believed to
make a pore by penetrating the membrane with their two hydrophobic core
helices arranged as a hairpin. Taking this into account, the “umbrella model”
was introduced, implying that the central helices of Bak and Bax (α5 and
α6) might insert across the MOM in an analogous way (Ros and García-Sáez,
2015; Cosentino et al., 2015; Annis et al., 2005). On that basis, several
groundbreaking studies have come up with different structural models for
Bax and Bak accommodation and aggregation in the MOM that defend or
dispute this initial view.
As previously mentioned, Bak is a membrane integral protein with a sole
interaction site for activation (BH groove). BH3 ligands bind transiently to
this site, inducing a structural reorganization that ends up in an increasing
distance between the core and latch Bak subdomains (Leshchiner et al.,
2013; Moldoveanu et al., 2013; Brouwer et al., 2014). This separation drives
the formation of Bak homo-dimers through their BH3 domains, which then
evolve into high order oligomers that enable MOM permeabilization (Dewson
et al., 2008). Although the longstanding hairpin insertion model for Bak
(and Bax) has been supported by several membrane accesibility studies
(García-Sáez et al., 2004; Annis et al., 2005), the trend is changing to a
situation where α5 and α6 only interact superficially with the membrane
(Bleicken et al., 2014; Westphal et al., 2014).
Bax is mainly a cytosolic protein in its inactive form, although it can
also loosely bind to the MOM (Schellenberg et al., 2013; Todt et al., 2013).
Its stepwise activation process begins with the binding of BH3-only pro-
teins (Bid, Bim and maybe Puma) to the non-canonical cleft (Edwards
et al., 2013; Gavathiotis et al., 2008; Lovell et al., 2008), which triggers the
freeing of α9 from the BH-groove. This is followed by the building of a
symmetric dimer interface by helices α2 to α4 and irreversible insertion in
the MOM. Bax membrane-embedded form displays helices α5, α6 and α9
inaccessible to water, therefore pointing them as the best candidates to be
tucked in the bilayer. In line with this observations, the initial “umbrella”
model for active Bax proposed the insertion of the α5-α6 hairpin across
the membrane, together with α9 (Annis et al., 2005). However, the only
helix hydrophobic enough to be fully inserted in the bilayer is α9, and this
model argues with evidences that show an unaltered and functional Bax
BH-groove after membrane spanning, which would not be possible in the
proposed arrangement.
Recent crystallography data with truncated forms of Bax in detergents sug-
gested that the core hairpin is indeed completely open during Bax activation,
resulting in the displacement of the latch and core domains, (like its “cousin”
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Bak) (Czabotar et al., 2013; Brouwer et al., 2014). This situation would
render an active Bax dimer where exclusively α9 would cross the membrane
and the rest of the protein would lay on the bilayer surface, with helices
α5 and α6 only partially inserted in it (Westphal et al., 2014) (Fig. 2.3).
Taking into account the crystal structure, the structure of active, full-length
Bax in the lipid membrane was further modeled by double electron-electron
resonance (DEER) spectroscopy (Bleicken et al., 2014). The main highlight
of this study confirms a partial opening of the α5-α6 hairpin, that allows
Bax to adopt a clamp-like conformation on the lipid bilayer, crutial for the
formation of active face-to-face dimers. These stable dimers would constitute
the building blocks for further Bax homo-oligomerization in the membrane,
observations that have also been confirmed by single-molecule studies with
recombinant proteins and supported bilayers (Subburaj et al., 2015). In
addition to the “dimerization domain” between α2 and α5, a flexible domain
comprising α6 to α9 slightly pinches the membrane and would be responsi-
ble for inter-dimer interactions. The amphipatic helix α6 of each monomer
would therefore lie on the surface of both membrane leaflets, favoring the
formation of a lipidic pore, as discussed below (section 2.2.4 on page 29).
Although the full-length membrane-bound structure of anti-apoptotic
Bcl-2’s remains a mystery, structural studies with detergents and with
peptides have nicely contributed to the literature on the association of these
proteins to the membrane (Losonczi et al., 2000; Chi et al., 2014). The
consensus view seems to be that they need to insert in the membrane to act
as inhibitory proteins (García-Sáez et al., 2004; Losonczi et al., 2000). Indeed,
the transmembrane tail of Bcl-xL is able to regulate the overall binding
affinity of the protein and mediate Bax retrotranslocation (Todt et al.,
2013). According to some reports, the integration of Bcl-xL in the membrane
may lead to BH3-ligand release and induce considerable structural changes
(Denisov et al., 2006; Basañez and Hardwick, 2008). A recent detergent-free
study with nanodiscs fostered debate on this belief, showing that both soluble
and membrane Bcl-xL conformations have high BH3 ligand affinity and that
membrane embedding does not induce major conformational changes in the
aqueous head, which retains the hydrophobic groove (Yao et al., 2015).
2.2.3. Bcl-2 family in action
It is not an easy task to unravel the precise mechanisms that this complex
family of proteins follow to orchestrate the cell fate, but tantalizing clues
have emerged over the years that give us a hint about how the Bcl-2 in-
teraction network, together with other cellular factors and the MOM itself,
harmonize in the course of apoptosis. In the literature, several models have
been proposed to explain how Bcl-2 interactions inhibit or advocate MOM
permeabilization, listed below (Fig. 2.4).
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Direct model
According to this theory, the effectors Bax and Bak are constitutively
inactive and have to be activated by BH3-only proteins in order to insert
and oligomerize in the membrane. The activation can proceed by two means,
which divide the BH3-only members in two subgoups (Letai et al., 2002;
Kuwana et al., 2005). On one hand, the “direct activators” (e.g. Bim, tBid)
can directly activate the killers Bax and Bak by binding. This is prevented
by the association of the anti-apoptotic members to these direct activators,
thereby inhibiting apoptosis. On the other hand, the “sensitizers” (e.g. Bad,
Noxa) act by displacing the direct activators from their complexes with the
anti-apoptotic members, therefore indirectly activating Bax and Bak. The
antiapoptotic members can also inhibit activated Bax and Bak, which are
released from the complex by both types of BH-3 only proteins. This scenario
was supported by the high efficiency observed for tBid to enhance Bax and
Bak permeabilizing function in model membranes (Kuwana et al., 2002;
Bleicken et al., 2010; Oh et al., 2010). The main drawback of this method is
the difficulty to detect interactions of the direct activators with Bax and Bak,
which led to hypothesize a transient, “kiss-and-run” mechanism (Eskes et al.,
2000; Wei et al., 2000; Lovell et al., 2008; Dai et al., 2011). However, new
lines of evidence in NMR experiments support a direct physical interaction
between Bax or Bak and the BH3-domains of Bid or Bim (Gavathiotis et al.,
2008; Moldoveanu et al., 2013; Czabotar et al., 2013).
Indirect model
This model, also known as “de-repression model” postulates that the effectors
are constitutively active, but bound to the anti-apoptotic homologs to stay
inhibited. Upon cell stress, the BH3-only proteins displace and neutralize
the anti-apoptotic proteins and free Bax and Bak to exert their pro-death
function (Willis et al., 2005, 2007). Among the pool of BH3-only members,
only Bid, Bim and Puma can interact with all the Bcl-2 type proteins,
being also the most powerful killers, whereas the rest have unequal binding
affinities. For example, Bad only binds to Bcl-2, Bcl-xL and Bcl-w; and
Noxa to Mcl-1 and A1 (Chen et al., 2005). However, more proofs are still
needed to assert that Bax and Bak are instrinsically active and this model
fails to explain why in vivo only a portion of Bax and Bak are sequestered
by the anti-apoptotic homologs.
Membrane embedded model
The previously described models propose irreversible protein-protein in-
teractions and do not pay attention to the role of the membrane in Bcl-2
interactions and functions. The “embedded together” model, which combines
the direct and indirect models, recognizes that the conformational changes in
most of the Bcl-2 members upon membrane insertion affect considerably their
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A Direct activation model
B Indirect model
C Embedded together model
D Unified model
Figure 2.4. Models for the regulation of apoptosis by Bcl-2 proteins.
binding patterns and in turn the global regulation of MOM permeabilization
(Leber et al., 2007; Lovell et al., 2008).
In this case, BH3-only proteins can spontaneously bind to membranes
and they directly activate Bax/Bak or sequester anti-apoptotic proteins to
hinder their prosurvival function. In general, the Bcl-2 proteins would exist
in an equilibrium between the cytosol and the membrane until the point
of no return in MOM permeabilization is reached, defined by Bax and Bak
insertion and oligomerization. Therefore, in this scenario, the membrane
becomes a regulating parameter for the interaction of all the functional Bcl-2
groups. The active role of the membrane has been embodied by advanced
fluorescence microscopy for Bcl-xL-tBid and Bax-tBid association (García-
Sáez et al., 2009; Liu et al., 2012). Moreover, only the membrane-bound
conformation of Bax is active and able to oligomerize (Annis et al., 2005;
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Bleicken et al., 2013). Importantly, additional mitochondrial membrane
proteins not related to the Bcl-2 family can play a regulatory role at the
membrane level: Mtch2 facilitates the recruitment of tBid to mitochondria
(Zaltsman et al., 2010; Shamas-Din et al., 2011) and Drp1 can enhance Bax
pore forming activity (Montessuit et al., 2010).
Unified model
As an extension of the “embedded together” model, the unified model
specifically accounts for the relative affinities of anti-apoptotic Bcl-2 proteins
for BH-3 only activators (Mode1) and for the effectors Bax and Bak (Mode
2). This model also connects the inhibitor effect of anti-apoptotic proteins
with the role of mitochondrial dynamics in apoptosis regulation. Some
anti-apoptotic members would inhibit only through Mode 1 (Bcl-2) or Mode
2 (Mcl-1), and some through both (Bcl-xL). Although both modes block
membrane permeabilization, the unified model postulates that preventing
Bax or Bak homo-oligomerization directly seems more efficient than doing it
by a detour through inhibition of BH3-activators (Llambi et al., 2011).
Last but not least, the MOM lipid composition cannot be left aside when
talking about the Bcl-2 network connections during apoptosis. Mitochondrial
lipids such as cardiolipin can influence Bax activity by binding to cBid
(Terrones et al., 2004) and they favor alterations in the bilayer properties
related to its remodeling and permeabilization (Unsay et al., 2013).
2.2.4. It is all about the pore
Following an apoptotic insult, both Bax and Bak insert extensively in the
MOM, where they oligomerize and arrange in clusters that ultimately trigger
MOM permeabilization (Lovell et al., 2008; Eskes et al., 2000; Korsmeyer
et al., 2000). Despite intense research, the molecular mechanisms underlying
this process are still unsettled.
The early view of the apoptotic pore considered Bax and Bak as regulators
of endogenous mitochondrial channels. Through physical interactions, Bax
and Bak would induce the opening of a permeability transition pore (mPTP)
located at mitochondrial contact sites, enabling the free flux of ions and
water into the matrix and the rupture of the MOM (Narita et al., 1998;
Brenner and Grimm, 2006). However, several arguments against the mPTP
hypothesis have arisen. For instance, genetic studies have challenged the
need of such components for apoptotic progression (Baines et al., 2005,
2007; Nakagawa et al., 2006) and the resulting cell death appearance via
transition pores differs considerably from the classical apoptotic morphology
(Nakagawa et al., 2006; Tsujimoto, Nakagawa, and Shimizu, Tsujimoto et al.).
Moreover, Bax/Bak double knock-out cells fail to die by many apoptotic
stimuli of the mitochondrial pathway, so they are essential for pore formation
(Wei et al., 2001).
29
2. Molecular pathways of apoptosis
To date, the most accepted model involves the formation of pores at the
MOM that allow cyt c and the other apoptotic factors to go through. This
is mostly based on the structural resemblance of the Bcl-2 homologs to
bacterial pore-forming toxins (Suzuki et al., 2000) and on the pore activity
detected for Bax and Bak in vitro using artificial model membranes in the
absence of any other mitochondrial components (Martinez-Caballero et al.,
2009; Basañez et al., 2002; Antonsson, 1997). However, the exact nature of
the apoptotic pore is not free of controversy. Some groups support a pore
fromed exclusively by proteins, while others are in favor of a proteolipidic
pore.
A Protein-lined pore
B Protein-lipid pore
Toroidal pore
C
Protein-lipid pore
Arc pore
Figure 2.5. Pore formation models for Bax. Left pannels show represen-
tative pore forming protein structures. Middle pannels show a side view cartoon
of the pore and right panels show the top view graphical representation. (A)
Barrel-state pore model formed by ClyA (PDB:2WCD). (B) Toroidal pore. Clamp
model proposed for Bax pore. (C) Arc pore. Pore formed by Bax monomers in
lipid nanodiscs. Adapted from (Cosentino et al., 2015)
Proteinaceous channel
The idea of a purely proteinaceous Bax an Bak channel was taken from
the beta-barrel pores formed by some toxins. Bax was postulated to create
a Mitochondrial Apoptosis-induced Channel constisting of up to 9 Bax
molecules (Martinez-Caballero et al., 2009) and a size ranging from 3 to
8 nm. This barrel-stave channel would allow to release proteins up to 17
kDa, but it is not permeable to bigger Dextrans (Dejean et al., 2010). An
alternative study showed that a tetrameric Bax channel is enough to release
cyt c from liposomoes (Saito et al., 2000), but none of these models is able
to justify the release of proteins of various sizes suggested for Bax-mediated
MOM pores.
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Proteolipidic pore
Current research appears to validate that Bax and Bak activity fits best
with the formation of mixed protein/lipid structures known as toroidal pores
(Qian et al., 2008), which are long-lived and large enough to release high
molecular weight molecules (Bleicken et al., 2013).
Toroidal pores avoid the high energetic cost of exposing their hydrophobic
helices to the aqueous environment by lipid bending and formation of a
highly curved, non-bilayer structure at the pore edge (García-Sáez, 2012)
(Fig. 2.5). In agreement with this, Bax can induce the redistribution of
lipids in liposomes and its central helix α5 is able to decrease the line tension
at the pore edge (Terrones et al., 2004; García-Sáez et al., 2007). The size
of Bax pores is tunable and can be regulated by protein density on the
membrane, indicating the ability of Bax to form relatively flexible structures
of different dimensions (Bleicken et al., 2013).
Recent structural studies have shown that active, full-length membrane-
embedded Bax arranges into symmetric dimers, which serve as building blocks
for the complex aggregates that mediate membrane disruption (Bleicken
et al., 2014; Subburaj et al., 2015). These structural data suggest that the
stabilization of the toroidal pore is accomplished by the Bax dimer lining the
highly curved lipid structure thanks to an opening of the hairpin between
helices α5-α6 in a suitable angle to clamp the membrane (Bleicken et al.,
2014). This property inherent to Bax should not be underestimated, since
it can be important for Bax interplay in other cellular processes such as
mitochondrial morphology (see section 2.2.5)
Strikingly, very recent work envisions another kind of protein–lipid pore
structure for Bax, where the protein forms an arc on one side of the pore, and
the lipids complete the toroidal structure (Xu et al., 2013; Salvador-Gallego
et al., 2016). The arc model has been postulated for multiple pore-forming
proteins like perforins or cholesterol-dependent cytolysins (Gilbert et al.,
2014; Leung et al., 2014; Metkar et al., 2015; Sonnen et al., 2014; Stewart
et al., 2015). So far, membrane perforation by this type of conformation had
only been proposed for β pore-forming toxins, but lipid pores containing
only one active Bax molecule have been recently visualized in lipid nanodiscs,
which strongly support the toroidal pore model for Bax function (Xu et al.,
2013).
Accordingly, superresolution microscopy has revealed arc-shaped Bax
assemblies in mammalian cells, which are enough to perforate the membrane
of lipid bilayers, as seen by AFM (Salvador-Gallego et al., 2016). Thus, it
could be hypothesized that the toroidal conformation of the lipids in the arc
pore architecture may be an intermediate stage during the assembly of full
ring protein-lined pores.
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2.2.5. Apoptosis and mitochondrial dynamics walk
hand-in-hand
At this point, we are convinced that mitochondria not only play a major role
in providing energy to the cell, but are also crucial for a number of cellular
processes including calcium homeostasis and lipid metabolism. Importantly,
these cellular organelles also constitute the main check-point of the apoptotic
cascade.
In contrast to the classical view of the organelle found in textbooks, live
cell microscopy has revealed that mitochondria form a dynamic tubular
network that is continuously fusing and dividing. The balance between
these two processes is known as mitochondrial dynamics and is essential
to maintain a functional organelle with proper shape. Indeed, aberrant
mitochondrial fusion and fission are tightly linked to a wide range of disorders,
like premature aging, neurodegenerative diseases, or cancer (Friedman and
Nunnari, 2014). The main regulators of mitochondrial dynamics are a group
of large dynamin-related GTPases (DRPs). Mitochondrial fusion requires
integral outer and inner membrane DRPs, named mitofusins and OPA1.
In vertebrates, mitofusin proteins (Mfn1 and Mfn2) reside in the MOM
and regulate its fusion (Legros et al., 2002; Chen et al., 2003), whereas
OPA1 is responsible for MIM fusion and cristae remodeling (Cipolat et al.,
2004; Frezza et al., 2006). These proteins self assemble in order to control
membrane remodeling and lipid mixing.
Mitochondrial division is catalyzed by the Dynamin-related protein 1
(Drp1 in mammals and Dnm1 in yeast), a predominantly cytosolic DRP
which drives back and forth to the MOM in healthy cells when required
for mitochondrial fission. In order to exert its function, Drp1 is believed to
oligomerize into helical structures that embrace and constrict mitochondria
until the complete fission of the outer and inner membranes is achieved
(Bleazard et al., 1999; Smirnova et al., 2001).
During apoptosis, the interconnected mitochondrial network disintegrates,
yielding smaller punctiform organelles. There is overwhelming evidence
corroborating the notion that mitochondrial dynamics can be regulated by
some apoptosis-related proteins, strongly supporting a tight link between
the two processes (Ugarte-Uribe and García-Sáez, 2014; Martinou and Youle,
2011).
Under normal growth conditions, Bax and Bak are required for the usual
rate of mitochondrial fusion and both can activate Mfn2, leading to the
assembly of progressive fusion sites (Karbowski et al., 2006). Along these
lines, in vitro studies showed that only the soluble, monomeric state of
Bax favors fusion, mainly when it is mediated by Mfn2-Mfn2 complexes.
However, this stimulation is blocked by the gathering of membrane-inserted,
oligomerized Bax (Hoppins et al., 2011). The anti-apototic protein Bcl-xL
also plays a housekeeping role in the regulation mitochondrial dynamics. In
neurons, Bcl-xL contributes to an increase in the mitochondrial biomass
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Figure 2.6. Interplay between Bcl-2 proteins and mitochondrial dy-
namics. (A) During apoptosis, Drp1 is recruited to mitochondrial foci to mediate
mitochondrial constriction and fission. (B) Model explaining the role of mitochon-
drial membrane hemifission or hemifusion intermediates in Bax oligomerization.
During apoptosis, Bax is recruited to the outer mitochondrial membrane by tBid
(or other BH3 only proteins) where it inserts. At the same time, Drp1 constricts
the organelle, triggering the formation of a hemifission intermediate that would
help Bax oligomerization.
and in the fusion/fission events. Moreover, it enhances the GTPase activity
of Drp1 and induces Drp1-dependent synapse formation (Li et al., 2008;
Berman et al., 2009).
During apoptosis, active Bax and Bak accumulate in specific foci where
mitochondrial fission takes place, colocalizing with Drp1 and Mfn2 (Kar-
bowski et al., 2002) (Fig. 2.6). Indeed, Drp1 stably oligomerizes in these sites
through SUMOylation in a Bax/Bak-dependent manner (Wasiak et al., 2007).
Although the mechanistic link between Drp1 and Bax or Bak remains vague,
a recent study argues that SUMOylation of Drp1 by the protein MAPL at the
ER/mitochondria contact sites stabilizes a signaling platform downstream of
Bax/Bak activation, required for efficient cyt c release (Prudent et al., 2015).
Drp1 can also form hemifusion intermediates in liposomes that stimulate
tBid-induced Bax oligomerization and cyt c release (Montessuit et al., 2010).
Such non-bilayer structures could be formed in cardiolipin-enriched sites,
and probably directly affect the integrity of the MOM by lowering the energy
required for toroidal pore formation and stabilization, providing another
link for mitochondria permeabilization and mitochondria fragmentation
(Martinou and Youle, 2011). This connection was confirmed by a study that
shows that the mitochondrial network shape strongly dictates the successful
coordination of a subset of BH3-only members to promote Bax-induced
MOM permeabilization and apoptosis (Renault et al., 2015). Besides Drp1,
the literature has documented a wide range of mitochondrial morphogenesis
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proteins that are also involved in apoptosis regulation (Table 2.1)
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Gene
prod-
uct
Process Loc.alizationL ss-of-function
phenotype
Apoptosis
regulation
References
Opa 1 Fusion MIM Fragmented
mitochondria.
Decrease in ATP
production,
potential and
oxygen consumption.
Downregulation
sensitizes cells to
apoptosis.
Remodeling of
mitochondrial cristae
during apoptosis.
Cipolat
et al.
(2006)
Scorrano
et al.
(2002)
Frezza
et al.
(2006)
Mitofusins
(Mfn1
and
Mfn2)
Fusion MOM Fragmented
mitochondria.
Changes in
potential.
Decline in
mitochondrial
function.
Developmental
defects.
Downregulation
sensitizes cells to
apoptosis.
Overexpression delays
apoptosis and inhibits
Bax oligomerization.
Interactions with Bax
and Bak.
Brooks
and Dong
(2007)
Karbowski
et al.
(2006)
Drp1 Fission MOM,
peroxi-
somes,
cytosol
Elongated
mitochondria and
peroxisomes
Downregulation, or
inhibition delays
apoptosis and cyt c
release.
Interactions with
Bcl-xL.
Stabilized on
mitochondria in a
Bax/Bak dependent
manner.
Li et al.
(2008)
Frank et al.
(2001)
Montessuit
et al.
(2010)
Fis1 Fission MOM
and
peroxi-
somes
Elongated
mitochondria
Downregulation delays
apoptosis,
overexpression induces
cell death.
Molecular interactions
with Bcl-xL.
James
et al.
(2003)
Lee et al.
(2004)
Mff Fission MOM
and
peroxi-
somes
Elongated
mitochondria
Downregulation delays
apoptosis.
Gandre-
Babbe and
van der
Bliek
(2008)
Otera et al.
(2010)
MID49
MID51
Fission
Fusion
MOM Elongated or
fragmented
mitochondria
Binding and inhibition
of Drp1.
Depending on the
stimulus, stimulation
of fission.
Xu et al.
(2016)
Palmer
et al.
(2013)
Mitofilin Cristae
structure
MIM Defective cristae Downregulation
induces apoptosis.
Yang et al.
(2012)
PARL Cristae
structure
(processing
of Opa1)
MIM Defective cristae Loss of expression
induces apoptosis.
Cipolat
et al.
(2006)
Table 2.1. Proteins implicated in regulation of mitochondrial dynam-
ics and apoptosis. Adapted from (Karbowski, 2010)
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3Microscopy techniques
3.1. Fundamentals of light microscopy
Back in the 16th century, curious spectacle-makers realized that an image
could be greatly magnified by using two or more lenses inside a tube. They
had just invented the first compound microscope. Years later, Robert Hooke
published his acclaimed microscope-based work “Micrographia”, where he
used the word “cell” for the first time in a biological context. For his studies,
he used a simple, single lens microscope illuminated by a candle, most likely
giving birth to the first light microscope. This technique was also chosen
by his colleague van Leeuwenhoek, who polished the device and grabbed
the attention of biologists with his images. It took a long time until the
compound microscopes could provide the same image quality as single light
microscopes, due to difficulties in solving spherical and chromatic aberrations.
With his theory for the resolving power of the microscope, Ernest Abbe
introduced the term Numerical Aperture (mathematical calculation of the
light-gathering capabilities of a lens) and clarified the differences between
resolution and magnification. Resolution is the ability to distinguish two
bright objects very closely located while magnification refers to the number
of times an image is enlarged. Abbe’s diffraction equation demonstrates
that the higher the numerical aperture and the shorter the wavelength, the
better resolution is achieved (Eq. 3.1).
d = λ2n sinα =
λ
2NA (3.1)
These findings, together with the implementation of Köhler Illumination,
which produces a bright, uniform lighting of the specimen, brought light
microscopy to a new level. It is important to note, that according to Abbe’s
equation, the maximum resolution of a light microscope is around 200 nm,
and the pattern of light emitted by the smallest possible fluorescent point
is actually a diffraction limited spot called point spread function (PSF).
Nowadays, microscope imaging has managed to go beyond this diffraction
limit, as we will discuss later.
3.2. Fluorescence microscopy
Fluorescence is the ability of certain molecules to absorb light at specific
wavelengths, which brings them to an excited electronic state, and to emit
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light of longer wavelengths as they return to the ground state after a short de-
lay, called fluorescence lifetime. After Stokes identified this wavelength shift
between absorbed and emitted photons, it turned out that many specimens
such us crystals, vitamins, and inorganic compounds could fluoresce when
irradiated with the proper light. This properties gave rise to the development
of a broad spectrum of fluorophores that enabled one to specifically stain
and observe intracellular components simultaneously in a non-destructive
manner (Lichtman and Conchello, 2005; Giepmans et al., 2006).
In a widefield fluorescence microscope, the sample is illuminated through
the objective lens with a high-intensity excitation light reflected from the
surface of a dichroic mirror. The fluorescence emitted by the specimen passes
back through the mirror and is focused to the detector through the same
objective. Selective spectral emission filters separate the illumination light
from the emitted fluorescence and an additional excitation filter blocks the
unwanted excitation wavelengths, therefore increasing the signal to noise
ratio. The image is brought into focus for the eye by the ocular lens or
digitally by charged-coupled device (CCD) cameras (Combs, 2010). The
main components of a fluorescence microscope are illustrated in Fig. 3.1.
Fluorescence microscopy has become a powerful tool to observe individual
organelles and macromolecular complexes simultaneously with different
colors, as well as to follow several pathways and dynamics in living cells that
would otherwise be unreachable (Lichtman and Conchello, 2005; Bacia and
Schwille, 2007). The final resolution is governed by the wavelength of light,
the objective lens, and the properties of the specimen itself. As a result, the
basic design of optical microscopes has not changed much since its origins.
However, the technique now has a much higher level of sophistication due to
a significant improvement in sample contrast and resolution.
3.2.1. Confocal microscopy
Confocal microscopy stands out over conventional widefield microscopy in
the way that it allows the elimination of out-of-focus glare, to collect several
thin optical sections from thick samples, and to improve the axial and lateral
resolution.
In contrast to the mercury or xenon lamps used standard widefield illumi-
nation, in a confocal microscope the specimen is scanned point by point (PSF
by PSF) by a laser beam to build the images. The emitted fluorescence is
then directed back to reach light sensing detectors such as photomultipliers
(PMTs). An aperture (pinhole) inserted in front of the detector, in the
conjugated focal plane to the point of focus in the sample, acts as a barrier
for the out-of-focus light. The pinhole size can be modulated, allowing more
or less light to arrive to the detector and enabling high contrasted, tunable,
optical sectioning. The laser beam intensity and wavelength are regulated by
an AOTF (Acousto-Optical Tunable Filter) and in some models a separation
of the visible spectrum wavelengths is achieved by a diffraction grating or
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Figure 3.1. Differences between Widefield and Confocal microscopes.
In confocal microscopy (B) the concept of illuminating the sample with excitation
light (e.g., blue light) and the sample emitting light with a longer wavelength
(e.g., green light) is identical to the general principles of fluorescence in wide field
microscopy (A). The differences to wide field microscopy are: (i) the excitation
laser light is scanned over the sample and the emitted light originates from this
area; (ii) on the detection beam path a pinhole aperture in front of the detector
prevents light emitted from above or below the focal plane (dotted lines) from
reaching the detector; and (iii) because only light from the focal plane (solid line)
reaches the detector an optical section is generated.
by a prism located in the light path before the detectors (Combs, 2010) (Fig.
3.1).
Even though it is an outstanding technique for biological applications,
Laser Scanning Confocal Microscopy has some limitations. It is in general a
rather slow process, so that in new spinning-disk confocal microscopes the
single pinhole is replaced by a spinning disk with multiple tiny apertures
that are scanned simultaneously. This increases temporal resolution but
impairs spatial resolution. In addition, visible linear wavelengths have a
low penetration depth in living tissues. This drawback is overcome with
two-photon laser scanning microscopes, which in addition detect scattered
photons and minimize the overall toxicity while imaging.
3.2.2. Fluorescence Correlation Spectroscopy (FCS)
Fluorescence correlation spectroscopy (FCS) is a powerful technique with
high spatiotemporal resolution to quantitatively determine the concentration,
diffusion properties and interactions of fluorescent molecules with single
molecule sensitivity. The most common implementation of FCS uses a
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confocal microscope to detect fluctuations of single molecules in a tiny,
sub-femtoliter detection volume, whose size depends on the pinhole aperture,
the intensity of the laser beam, and the light wavelength. Such fluorescent
fluctuations mostly rely upon the fluorophore’s mobility, but are also affected
by its photophysical properties, concentrations and brightness (Ries et al.,
2012).
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Figure 3.2. FCS principle. (A) Fluorescence molecules diffusing through
the detection volume produce intensity fluctuations. (B) The fluctuations are
temporally autocorrelated to measure the self-similarity of the signal over time
and fitted with a model function. (C) In scanning FCS, the detection volume is
scanned through the membrane. The line scans are arranged and aligned to correct
for membrane movements. For each line scan, the detected photons are summed
up to create a fluorescence intensity trace, which is auto-correlated and fitted with
diffusion models. (D) Expression used to calculate the temporal autocorrelation
analysis. G is the autocorrelation function, F is the fluorescence intensity as a
function of time t, and τ is the correlation time. (E) Two focus dual-color FCS:
fluorescence molecules differently labeled diffuse through two detection volumes
separated by a known distance d. If the two molecules bind and co-difuse, there
will be a correlation between the green and magenta intensities, leading to a
positive cross-correlation amplitude (F)
To perform FCS, PMT detectors are replaced by highly sensitive avalanche
photo diodes (APDs), which detetect the fluorescence as a stream of single
photon arrival times, which constitute the raw data. These times are used
to calculate the fluctuating intensity of fluorescence, which is then analyzed
by applying the temporal autocorrelation of the recorded intensity signal.
The autocorrelation analysis is a mathematical tool that measures the self-
similarity of the signal with time, reflecting the probability that the signal
at different times still belongs to the same molecular event.
In order to calculate the parameters of interest, the measured correlation
curve is then fitted with a mathematical function that models the origin of
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the fluorescence fluctuations inside the detection volume, according to the
characteristics of the system under investigation (Fig. 3.2). The parameters
that are considered in this model are usually the size and shape of the detec-
tion volume, the brightness and concentration of the fluorophore, and other
photophysical phenomena generating additional fluctuations (e.g. triplet,
blinking). The result is an autocorrelation curve whose decay reflects the
residence time of the molecules in the detection volume (Fig. 3.3) and whose
amplitude is inversely proportional to the number of observed molecules and
thus to the concentration of fluorescent particles (Ries and Schwille, 2006;
Subburaj et al., 2013).
Some variations of FCS have been introduced that enable the application of
this technique to a broader range of biological systems, specially membranes:
• Fluorescence cross-correlation spectroscopy (FCCS): Allows for the
measurement of interactions between molecules labeled with differ-
ent fluorophores that diffuse together through the focal volume by
temporally correlating two or more fluorescence channels.
• Scanning FCS (line, linear, circular): Allows for the study of slow
diffusing species typical of lipid membranes. The detection volume is
scanned through the sample so the residence time of the fluorophore in
it is much smaller, thus decreasing the probability of photobleaching
(Ries and Schwille, 2006).
• Two focus FCS: Provides a calibration free method, since it measures
the intensity fluctuations from two partially overlapping foci that are
separated by a known distance. Taking the distance between two
volumes as a reference avoids errors in observation volume calibration
when using samples with a refractive index mismatch (Fig. 3.2e,f).
• Z-scan FCS: The focal volume is placed at different positions along
the z-axis, making it possible to measure above, below and at the
membrane.
In conclusion, FCS is an excellent approach to investigate dynamic processes,
due to the ability to measure diffusion coefficients, fluorophore concentra-
tions, particle sizes, chemical reactions, conformational changes, and bind-
ing/unbinding processes. Moreover, the combination of this technique with
many different imaging methods, such as laser scanning confocal microscopy,
two-photon microscopy, total internal reflection fluorescence microscopy,
STED, and others, has made it highly advantageous for cell biology (Bacia
et al., 2014).
3.2.3. Other confocal-based techniques
Improvements in microscopy techniques and the development of new flu-
orescent proteins have opened the door to confocal-based approaches for
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Figure 3.3. FCS autocorrelation curve: dependence on concentration
and diffusion of the fluorescent molecules. Fast diffusion results in fast
intensity fluctuations and a decay of the autocorrelation curve at smaller lag times
τ . If the concentration of molecules is low, the amplitude of the autocorrelation
curve is higher and the intensity fluctuations larger.
the research of the interactions and dynamic processes that govern the
organization and structure of living cells. Among them, we can highlight
Fluorescence recovery after photobleaching (FRAP), Forster resonance en-
ergy transfer (FRET) and Fluorescence-lifetime imaging microscopy (FLIM)
(Ishikawa-Ankerhold et al., 2012).
The basic principle of FRAP is to photobleach a small region within
a fluorescently labeled membrane and record the time necessary for the
bleached region to recover. It was first described in the 1970s as a tool to
follow protein or lipid mobility on the cell-surface, but its applications have
been extended to the study of lipid fluctuations, vesicle transport, or cell
adhesion, among others (Wong and Wessel, 2008; Zhang et al., 2010). Varia-
tions of this technique include FLIP (fluorescence loss in photobleaching),
photoconversion, or photoactivation.
FRET serves to discern interactions in the nanometer range between
proteins tagged with spectrally different fluorophores. It is based on the
non-radiative energy transfer from an excited donor molecule to an acceptor
molecule. In turn, the acceptor emits a fluorescence photon and the fluores-
cence lifetime of the donor molecule decreases. In this way, the interaction
between both molecules is calculated by determining the efficiency of the
transfer, which is inversely proportional to the sixth power of the distance
between donor and acceptor. FRET requires an overlap of the emission
spectrum of the donor with the excitation spectrum of the acceptor, and a
favorable orientation of the dipoles.
In FLIM, the fluorescence lifetime, rather than the emission spectra, is
used to create the image. When an excited fluorophore returns to the ground
state, it can do so by emitting a fluorescence photon, converting the energy
internally, or transferring the energy to the environment. The environment
can affect how long the fluorophore stays in the excited state before emitting
the photon to relax, resulting in a decay in the fluorescence lifetime. This
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decay measured in FLIM mostly depends on the ion concentration, oxigen,
pH, or protein binding. (Ishikawa-Ankerhold et al., 2012).
The combination of FLIM and FRET provides great advantages, such as
internal calibration and increase in spatio-temporal resolution (Sun et al.,
2011; Wallrabe and Periasamy, 2005). In FLIM-FRET, the donor lifetime is
measured in presence and absence of the acceptor. Since the fluorescence
lifetime is an inherent property of the dye and it does not depend on the
intensity, this technique allows to better estimate the distance between the
labeled proteins regardless of the possible intensity artifacts due to expression
level variations or external effects (Sun et al., 2011; Wallrabe and Periasamy,
2005).
Useful terms in microscopy
Magnification: Ability to enlarge an image produced by an optical
system in comparitson to its true size.
Resolution: Smallest distance apart at which two points can be seen
separatelly.
Stoke’s shift: Difference in wavelegth between the maxima of the
absorpbtion and emission spectra of a fluorophore.
Numerical aperture (N.A.): Dimensionless number that charac-
terizes the lens opening angle and measures the objective’s
resolving power and the brightness of the image.
Point Spread Function (PSF): 3D diffraction pattern resulting
from the image of a single point object by an objective lens.
Airy disc: Central difraction maximum of the cross-section of a
perfectly focused spot (cross-section of the PSF). 1 Airy unit
is referred to the pinhole diameter that gives the maximum
theoretical signal.
Gain: Detector’s sesitivity (voltage). It adjusts the signal amplifica-
tion at the detector.
Offset: Minimal signal intensity detected by the sensor. It adjusts
the background level.
Photobleaching: Irreversible destruction of a fluorophore
Blinking: Random fluorescence intermittency of a fluorophore be-
tween ON and OFF states.
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3.2.4. Super-resolution microscopy
There is no doubt about the potential of the fluorescence microscopy tech-
niques explained above in biology, but one issue is that the relevant size
range of many cellular structures is much smaller than the presumed 200
nm driffaction barrier (Fig. 3.4). Lately, “super-resolution” techniques
have circumvented this limitation to explore the cell’s internal life and its
processes with up to one magnitude higher in resolution (Mund et al., 2014).
The great feat of bringing optical microscopy to the nanodimension was
awarded with the Nobel Chemistry Prize recently.
A (0.2 µm)bbe´s diffraction limit
1nm10 nm100 nm1µm10µm100µm1 mm
small moleculeproteinvirusmitochondrionbacteriummammalian cellhairant
Figure 3.4. Representative sizes of microscopic samples. Illustration: ©
Johan Jarnestad/The Royal Swedish Academy of Sciences
Single-molecule Localization-based Microscopy
The term single molecule localization microscopy (SMLM) includes the super-
resolution techniques based in the precise localization of isolated emitters,
such as Photo-activated localization microscopy (PALM) (Betzig et al., 2006)
and stochastic optical reconstruction microscopy (STORM) (Rust et al.,
2006).
As previously mentioned, the width of the point spread function (PSF)
limits resolution in optical microscopes. Nevertheless, the position of the
point source is at the center of the spot and can be precisely estimated
via centroid calculation or PSF fitting to a known geometrical function.
This method is only reliable for isolated emitters. However, the imaging of
dense biological samples produces generally many overlapping PSFs, so as
to overcome this issue in SMLM controlled pulses of laser light separate the
emitters over time. If only some fluorescent molecules are simultaneously
active, their positions can be accurately discerned. Afterwards, those emitters
are bleached or converted to a dark state and another set of fluorophores
becomes activated. Iteration of this process for enough number of times
ensures that all the flourescent molecules are eventually localized. A super-
resolved 2D or 3D image is then reconstructed by superimpossing all the
individual recordings. Therefore, the resolution of the final image is limited
by the number of localizations and the localization precision, instead of by
diffraction (Lakadamyali, 2014; Mund et al., 2014).
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-
Figure 3.5. Super-resolution microscopy imaging principles. (A) In
SIM the sample plane is excited by a nonuniform wide-field illumination. Laser
light passes through an optical grating, which generates a stripe-shaped sinusoidal
interference pattern. (B) In STED microscopy the focal plane is scanned with
two overlapping laser beams. While the first laser excites the fluorophores, the
second longer wavelength laser drives the fluorophores back to the ground state
by the process of stimulated emission. (C) Single molecule localization microscopy
assures that only a relatively low number of fluorophores are in the emitting
(active) state. This is achieved either by photoactivation, photoswitching, triplet
state shelving, or blinking. These molecules are detected on the CCD camera
as diffraction-limited spots, whose lateral position is determined with very high
accuracy by a fit. Schermelleh et al. (2010)
SMLM requires bright fluorophores which switch between “on” and
“off” fluorescent states stochastically. In order to maximize resolution,
the samples should also be densely labeled. A wide set of fluorophores
have been optimized for the different SMLM methods, including photoac-
tivable or photoswitchable FPs (PA-GFP, mMaple), organic dyes that can
be switched under special buffer conditions (Alexa647, Cy5, CF680), or
activator-photoswitacble dye-pairs (Cy3-Cy5) (Betzig et al., 2006; Heile-
mann et al., 2008; Rust et al., 2006). Due to the long measurements required
for image acquisition, most of the localization-based investigation is per-
formed with fixed samples. However, some research groups have taken the
leap into live cell imaging (Huang et al., 2013; Shroff et al., 2008; Jones
et al., 2011).
SMLM is admirably contributing to decipher the inner world of the cell.
It has been a powerful tool to investigate the organization the cytoskeletal
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structure (Xu et al., 2013), the endocytic machinery (Picco et al., 2015), the
chromatin (Ricci et al., 2015), or the proteins that form the nuclear pore
complex (Szymborska et al., 2013). This technique has also provided new
insight into the proteins related to diseases like Huntington’s or Alzheimer’s
(Ries et al., 2013; Duim et al., 2011).
Stimulated Emission Depletion Microscopy (STED)
In order to improve resolution, this technique exploits the non linear response
of a fluorophore to its illumination by applying the principles of reversible
saturable optical fluorescence transitions (RESOLFT) (Hell, 2003; Hofmann
et al., 2005).
The STED approach is based on a confocal microscopy setup, but it uses
two overlapping laser beams as the illumination source. The first one excites
the fluorophores into a higher electronic state and the second, doughnut-
shaped depletion beam (STED beam) quenches all the fluorescence except
the one detected in the center of the doughnut. Once excited, the electrons
are stimulated to emit a photon with the wavelength of the STED beam, but
no fluorescence photon. This high intense depletion beam is red-shifted with
respect to the excitation beam, allowing one to differentiate the two types
of photons and to discard the stimulated ones. As a result, the fluorescence
emission is confined to a sub-difraction limited spot, which improves the
resolution. The scanning of the complete sample with these coupled lasers
yields an image with a resolution better than Abbe’s stipulated limit (Klar
et al., 2000).
Although theoretically STED has no optical limit in resolution, in the
practice the resolution is restricted by the photo-physical properties of the
dyes (Jakobs, 2006; Hell, 2007). Apart from the commonly available FPs and
organic dyes, better imaging is now possible thanks to quantum dots and
tag-mediated labeling of fusion proteins with fluorescent molecules (Urban
et al., 2011; Hanne et al., 2015). Since it was first develpoed, STED has been
applied to the study of many proteins and processes at a sub-organelle level,
such as mitochondrial proteins (Nienhaus and Nienhaus, 2015; Schmidt et al.,
2009). Live cell STED has also allowed one to follow organelle dynamics
(Hein et al., 2008; Westphal et al., 2008) and even image neurons in a living
mouse at high resolution (Berning et al., 2012) .
(Saturated) Structured Illumination Microscopy—(S)SIM
SIM also uses two laser beams to excite the fluorophores in the specimen.
However, instead of scanning the sample like in STED microscopy, SIM
relies in the interference of the two beams to create periodic line patterns
of bright and dark stripes. This sinusoidal illumination pattern has a peak
intensity that does not result in fluorescent saturation, so the resolution
can only be increased by a factor of two (Heintzmann and Cremer, 1999;
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Gustafsson, 2000). However, SIM was proven very useful in live-cell imaging
thanks to its low power illuminating source (Gustafsson, 2008).
In order to increase resolution, one can optically saturate the fluorescence
markers in the sample to achieve a nonlinear response of the fluorescence
signal (Gustafsson, 2005). The major drawback of (S)SIM is that the
saturating excitation power causes extensive photodamage and reduced
photostability of the fluorophores.
3.3. Labeling strategies
Fluorophores are molecules that emit fluorescent light when excited and
have characteristic spectra, light absorbance efficiency, fluorescence lifetime,
quantum yield, and photobleaching properties. Some approaches to obtain
fluorescent samples for imaging are listed below.
Dyes
Synthetic dyes are bright and photostable and have engineered reactive
groups which allow for their attachment to the biological molecules of
interest (e.g. Xanthene, Cyanine, Alexa or Atto dyes).
Some of them are instrinsically fluorescent and have very specific binding
properties, such as the DAPI or Hoechst nucleic acid stain, the mammalian
actin fibre dye phallodin, or the anterograde neuron stain DiI. Since they
change their fluorescent properties when bound to different amounts of
molecules, they can be used directly in live cells (Progatzky et al., 2013).
Other synthetic fluorophores require a transportation system such an
antibody that binds a specific target within the cell. These are used in
immunofluorescence of fixed samples, where they are conjugated to a primary
antibody or to a secondary antibody that binds to the primary, which
recognizes a determined antigen (Hilderbrand, 2010).
Quantum dots
Quantum dots are nanometer-sized particules of purified semiconductors that
exhibit long-term photo-stability as well as bright emission. They can be
excited by wavelengths up to the blue range and their emission wavelength
increases with the diameter (from 3 to 10 nm) (Reed et al., 1988). These dots
are usually coated with an additional semiconductor shell and a polymer to
enable coupling to proteins, oligonucleotides, or small molecules which then
bind to the target. Due to their flexible capabilities, they can also be used
for direct staining of cells (Hoshino et al., 2012).
Fluorescent proteins (FP)
Fluorescent proteins (FP) are genetically encoded fluorophores that consti-
tute non-invasive markers for cells and do not need exogenous substrates
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or co-factors to stain their target. A reporter gene encoding the FP is
introduced into living organisms through cell transfection or injection with
viral vectors in order to visualize the localization of the gene product. The
first FP found was GFP, in the jellyfish Aequorea victoria (Shimomura et al.,
1962; Ormö et al., 1996). The color palette has now been extended with the
identification of FP from other species (e.g. dsRed or Kaede) and improved
variants have been developed by mutagenesis techniques (Shaner et al., 2005).
Interestingly, the photoactivable and photoconvertible fluorescent proteins,
which undergo specific changes in their spectral properties after activation
with laser light of determined wavelength and intensity, have become partic-
ularly useful for the study of organelle dynamics (Lippincott-Schwartz et al.,
2003; Chudakov et al., 2004).
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Apoptosis is essential to human development. The malfunctioning of this pro-
cess can lead to the progression of autoimmune diseases or cancer. Therefore,
the regulation of apoptosis is a fundamental question in biology. The point of
no return in a cell’s commitment to die by apoptosis is the permeabilization
of the MOM, mediated in the last instance by the pro-apoptotic protein Bax.
However, the molecular mechanisms underlying this process, as well as the
supra-molecular arrangement of Bax in mitochondria remain enigmatic. In
order to gain insight into Bax organization, and its relationship with MOM
permeabilization and mitochondrial dynamics, the following objectives were
proposed:
1. Elucidation of Bax assembly during apopotosis at the nanoscale using
fluorescence super-resolution microscopy.
2. Determination of Bax orientation on mitochondria via dual-color super-
resolution microscopy and characterization of Bax pores in vitro with
atomic force microscopy.
3. Characterization of Bax influence in the mitochondrial fragmentation
machinery by investigating its interplay with Drp1.
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5Materials
5.1. Buffers
Anode I
0.3 M Tris 10%
Methanol pH 10.4
Anode II
25 mM Tris
10% methanol
Cathode
25 mM Tris
40 mM glycin
10% methanol pH 9.4
GTPase
20 mM HEPES pH 7.4
150 mM KCl
2 mM MgCl2
Imaging
50 mM Tris/HCl pH 8
10 mM NaCl
10% (v/w) glucose
35 mM cysteamine (MEA)
0.5 mg/mL glucose oxidase
40 µg/ml catalase
Laemmli 6x
4% SDS
10%
ß-mercaptoethanol
20% glycerol
0.004% bromophenol
blue
0.125 M Tris HCl
Lysis
10 mM Tris/HCl pH 8
150 mM NaCl
1 mM EDTA
1% NP40
0.1% SDS
MB
210 mM mannitol
70 mM sucrose
1 mM EDTA
10 mM Hepes pH 7.4
SDS Running
25 mM Tris
190 mM glycine
0.1% SDS
SLB
150 mM NaCl
10 mM HEPES pH 7.4
TBS-T
40 mM Tris
5 mM sodium acetate
1 mM EDTA
20 mM Tris/HCl
135 mM NaCl
1 M HCl pH 7.6
0.1% Tween 20
TAE 1X
40mM TRIS
20mM acetic acid
1mM EDTA.
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5.2. Cell culture volumes
The transfection volumes are shown per well and the OptiMEM volume
refers to the total quantity.
Vessel Seeding Growth DNA(µg) Lipofectamine OptiMEM (ml)
density medium (ml) 2000 (µl)
8-well 0.5-0.8·105 0.25 0.1-0.2 0.25 0.05
µ-chamber
6-well 1-2·105 2 0.3-0.6 1-1.5 0.2
plate
10 cm 4-6·105 7 1-2 4.5-6 1
plate
15 cm 1-2·106 15 5-8 8-10 3
plate
5.3. Antibodies
Name Catalog # Dilution Application
AF647-anti-GFP nanobodies Chromotek (home labeled) 1:2·103 IS
Actin Milipore 691001 1:104 WB
Bax Cell Signaling 2772S 1:103 WB
Cox IV Cell Signaling 11967 1:50 WB
Drp1 Cell Signaling 26954 1:30 IS
VDAC Abcam 14734 1:103 WB
Anti-mouse Jackson 115-035-003 1:104 WB
Anti-rabbit Jackson 111-035-003 1:104 WB
CF680 anti-mouse Sigma SAB4600371 1:500 IS
WB = Western Blot, IS = Immunostaining
5.4. Fluorescent proteins
Gene BackboneCloning
sites
Primers for cloning (5’-3’)
pEGFP-Bax pEGFP HindIII Gift from N.Brady
-C1 EcoRI
Mito-dsRED pEYFP - Gift from DKFZ Genomics Core Facility
-Mito
mMaple-Mito pEYFP BamHI CGCGGATCCATGGTGAGCAAGGGCGA
-Mito XbaI GCTCTAGATTACTTGTACAGCTCGTCC
mMaple-Bax pEGFP NheI CTAGCTAGCACCATGGTGAGCAAGGGCGA
-Bax HindIII CCCAAGCTTGCACTGAGCAGCGTAATCTG
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6.1. Cells thawing, passing and freezing
Reagents Materials
• Cells
• PBS
• Trypsin
• Cell culture medium (HeLa:
DMEM + 10% FBS + 1%
Pen/Strep. MEFs: DMEM +
10% FBS + 1 % Pen/Strep +
50 µM β-mercaphtoethanol.
HCT116: McCoy 5A + 10%
FBS + 1 % Pen/Strep)
• Freezing medium (Cell culture
media with 20% FBS and 10%
DMSO)
• Falcon tubes
• 1 ml-2 ml cryovials
• Cell culture dishes or flasks
• CO2 incubator
• Laminar hood
• Vacuum pump
• Centrifuge
Procedure
1. Thawing and recovery of cells from liquid nitrogen must be done
quickly. Prepare pre-warmed medium in advance. Remove cryovials
from liquid nitrogen and immediately place in 37 °C water bath and
quickly shake until about 80% has thawed (this should not take more
than a minute).
2. Quickly pipette out into a falcon with 9 ml cell culture media and
centrifuge at RT, 1200 rpm for 3 min.
3. Remove the media, dissolve the pellet in fresh media, transfer to a 25
cm2 or 75 cm2 flask and place in the incubator. Let the cells attach to
the flask for at least 24 h before passing them.
4. To passage cells, remove and discard the medium from the cell culture
vessel, wash gently with pre-warmed PBS and add pre-warmed trypsin
(see Table 5.2 for appropiate volumes). Place in the incubator for 3
min (or until the cells have detached).
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5. Once cells are detached, add back 5-10 ml media and transfer to a 15
ml Falcon. If cells are only used for subculturing, dilute the desired
amount of cells in fresh media in a new cell culture vessel and place in
the incubator. If cells are going to be frozen, continue to step 6.
6. To ensure the cells are healthy enough for freezing, the viability should
be over 90%. Count the cells using trypan blue for a viable cell count.
Spin down at 1500 rpm for 5 minutes and remove medium.
7. Resuspend cells in enough freezing medium to create a cell suspension
of 106 cells per ml (do not pre-warm freezing medium). Pipette up and
down to ensure even mixture and aliquot 1 ml into storage cryovials.
8. Transfer cells immediately to a freezing container and place them at
-80 °C overnight before permanent storage in liquid nitrogen. This step
must be done as soon as the cells are in freezing media. DMSO is toxic
to cells and so should not be exposed to the cells at room temperature
for any longer than necessary.
6.2. Confocal live cell imaging
Reagents Materials
• Cells
• Phenol red free cell culture
medium
• PBS
• Staurosporine
• Glass bottom 8-well chamber
• Confocal microscope LSM 710
(Carl Zeiss, Jena, Germany)
with a ConfoCor3 module and a
C-Apochromat 40x, 1.2 N.A.
water immersion objective
Procedure
1. Grow cells on 8 well µ-slide for 24h to 70-80% confluency and transfect
them if needed (see section 6.3).
2. Maintain cells in 200-300 µl of phenol-red free DMEM at 37 °C and
5% CO2 for imaging. For apoptosis induction, add Staurosporine to
the medium (1 µM final concentration).
3. Image acquisition: Use the 40x, N.A. 1.2 water immersion objective
and select the appropriate optical setup for the fluorophores under
study. For z-stack, time series measurements, choose the following
settings:
a) Frame: typically 512x512 for a good compromise between image
quality and size.
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b) Direction bidirectional.
c) Averaging: choose at least an averaging of 2. Increase it for
single snapshots to have the best resolved image. For time series
experiments, find a compromise between the averaging and the
scan time to have a sufficient resolution in the desired scan time.
d) Scanspeed: adjust it depending on the time interval settings.
e) Z-stack: focus on the bottom on the cell, “set first” plane, then
focus on the top and “set last”. Choose a range of stacks with
the smallest interval possible.
f) Time series: Choose the cycles and interval time according to
the specific measurement. Be sure that the interval time is long
enough to acquire one z-stack image with the chosen acquisition
mode and averaging.
6.3. Cell transfection
Reagents Materials
• Adherent cells (70% confluency)
• PBS
• Trypsin
• Cell culture medium (HeLa:
DMEM + 10% FBS + 1 %
Pen/Strep. MEFs: DMEM +
10% FBS + 1 % Pen/Strep +
50 µM β-mercaphtoethanol.
HCT116: McCoy 5A + 10%
FBS + 1 % Pen/Strep)
• Opti-MEM medium
• Transfection reagent
(Lipofectamine 2000)
• DNA
• Falcon tubes
• Cell culture dishes or flasks
• CO2 incubator
• Laminar hood
• Vacuum pump
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Procedure
1. One day before transfection, seed 5000-8000 cells per well in 200 µl
growth medium (Representative protocol for transfection in 1 well of
a glass bottom 8-well chamber. See section 5.2 for extrapolation).
2. For each transfection sample, prepare complexes as follows:
a) Dilute DNA (0.1 to 0.2 µg) in 25 µl of Opti-MEM. Mix gently
b) Mix Lipofectamine 2000 gently before use, then dilute 0.5 µl in
25 µl of Opti-MEM. Incubate for 5 minutes at room temperature.
Note: Proceed to step 2c within 25 minutes.
c) After the 5 minute incubation, combine the diluted DNA with
diluted Lipofectamine2000 (total volume = 50 µl). Mix gently
and incubate for 20 minutes at room temperature (the solution
may appear cloudy). Note: Complexes are stable for 6 hours at
room temperature.
3. Add the 50 µl of complexes to each cell-containing wells and 200
µl medium. Mix gently by rocking the plate back and forth. Note:
Although not required, you may replace the old growth mediums
added the day before transfection (step 1 of this procedure) with fresh
medium.
4. Incubate cells at 37 °C in a CO2 incubator for 18-48 hours prior to
testing for transgene expression. (Note: For plasmids containing Bax,
do not let the transfection proceed for more than 12 hours to avoid
massive cell death). The medium may be changed after 4-6 hours.
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6.4. Western-blot
Reagents Materials
• Cells
• PBS
• Lysis Buffer with protease
inhibitors
• Bradford reagent
• Water
• BSA protein standard
• 6x Laemmli Buffer
• SDS Running Buffer
• Transfer buffers (Anode I,
Anode II and Cathode)
• Milk (5% w/v in PBS)
• Antibodies
• Methanol
• TBS-T
• Falcon tubes
• PAGE gels
• Electrophoresis chamber
• Transfer system (Trans-Blot,
Biorad)
• PVDF membranes
Procedure
1. Place the cell culture dish in ice and wash the cells with ice-cold PBS.
2. Drain the PBS, then trypsinize the cells.
3. Inactivate trypsin with cell culture medium and transfer the suspension
into a tube. Centrifuge at 4 °C, 1500 rpm for 5 min. Discard the
supernatant, resuspend the pellet with PBS and spin down again for 5
min.
4. Drain PBS and resuspend the pellet in 50 to 200 µl Lysis Buffer +
protease inhibitors. Transfer to an 1.5 ml tube and incubate on ice for
30 min.
5. Centrifuge at 4 °C, 14000 rpm for 30 min.
6. For total protein extraction, gently remove the tubes from the cen-
trifuge and place on ice, aspirate the supernatant and place in a fresh
tube kept on ice. Discard the pellet.
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7. Perform a Bradford assay with BSA as a protein standard (concentra-
tion range for the standard curve: 0 to 1.5 mg/ml).
8. Add Buffer Laemmli 6x to the protein suspension and boil the mixture
at 99 °C for 5 min.
9. Load the samples in the PAGE gels (typically 10-15 µg per well) and
run the gel at constant voltage (80V) while the samples are still in the
stacking gel. Turn up the voltage to 120-150V afterwards if desired.
10. Transfer the proteins to a PVDF membrane:
a) Equilibrate the gel in Cathode buffer for 10 min to remove residual
SDS. (very important for a successful transfer).
b) Activate the PVDF-membrane in methanol, water and anode II
Buffer (1 min in each).
c) Immerse the Whatman papers in the correct Buffer until wet (see
d).
d) Mount the transfer sandwich, membrane and gel in the following
order (from bottom to top): 2 Whatman papers in Anode I Buffer
- 1 Whatman paper in Anode II Buffer - membrane - Gel - 3
Whatman papers in Cathode Buffer. Proceed with the transfer.
11. Block the membrane with 5 % milk or with 5 % BSA in TBS-T as
specified on the antibody datasheet.
12. Incubate in a 50 ml falcon with the primary antibody diluted into 10
ml of 5 % milk or into 5 % BSA n TBS-T. Rotate overnight at 4 °C.
13. Wash the membrane 3 times with TBS-T.
14. Incubate with secondary antibody for 1 h at room temperature.
15. Develop membrane.
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6.5. Single-molecule localization microscopy
Reagents Materials
• PBS
• PFA 4%
• Antibodies
• BSA
• Glycine
• Triton X-100
• Ammonium chloride (NH4Cl)
• Imaging buffer
• Vacuum pump
• Humid chamber (plastic box
with wet filter paper and
parafilm)
• Tweezers
• Custom-made microscope
Procedure
1. Immunostaining:
a) Grow cells on 24cm round glass coverslips for 24h to 70-80%
confluency and transfect (see section 6.3).
b) Fix cells in 4% PFA in PBS for 10 min at RT.
c) Incubate the coverslides in 50 mM NH4Cl (in PBS) for 15 min.
d) Permeabilize cells with 0.25% Triton-X100 (in PBS) for 5 min.
e) Wash cells 3 times for 5 minutes with PBS.
f) Block for 45 min with 1% BSA (in PBS).
g) Incubate slides with 50 ng/ml of AF647-anti-GFP nanobodies
(1/2000) or the appropiate primary antibody diluted in 1% BSA
(in PBS) for 90 min. Incubate with the first antibody (1:50 to
1:500 dilutions in BSA) for 90 minutes in the dark. For this step,
put the antibody drop on a wet chamber (15 µl for 15 mm slides,
25 µl for 25 mm slides) and place the slide on the drop with
the cells facing the liquid. In order to achieve an homogeneous
incubation, touch first the drop with border of the slide and let
it fall on it. Be sure that there are no air bubbles between the
paper and the parafilm in the chamber.
h) If secondary antibody labeling is required, dilute it in 1% BSA
(in PBS) and incubate the slides for 30 min.
i) Return the slides to the cell culture well-plate with the cells facing
up and wash 3 times with PBS. Keep in PBS in the dark at 4 °C
until imaged.
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2. Mount the coverslides with the cells facing up covered with 300 µl of
Imaging Buffer and image in a custom-made microscope.
3. The specific SMLM measurements in this work were done as follows:
we used an exposure time of 15 ms for single color and 30s for dual
color measurements and an EM gain of 100. Imaging laser intensity
at 640 nm was 2.5 kW/cm2 and the 405 nm activation laser intensity
was automatically adjusted to keep a constant number of localizations
per frame. Typically 70000-100000 frames were recorded. Analysis
was performed using a custom Matlab script. Localizations with
uncertainties above 15 nm were discarded.
4. Image analysis and quantification of structures was done with ImageJ.
The histogram bin number was determined by the square root of the
number of events.
6.6. Cloning
Reagents Materials
• HF Buffer
• dNTP mix
• Primers
• Template DNA
• Agarose
• Restriction enzymes
• Phusion polymeraser
• T4 Ligase
• PCR purification Kit
• Gel extraction Kit
• MiniPrep Kit
• PCR machine
• Electrophoresis chamber
• UV gel developer
• Thermoblock
Procedure
1. Amplify the DNA product by PCR as in the Phusion Polymeraser
manufacturer’s protocol.
2. Purify PCR product with the purification kit (check the correct isola-
tion of the product by running an aliquot on an agarose gel).
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3. Digest PCR product and the backbone vector with the appropriate
enzymes (use conditions and buffers recommended by NEB).
4. Run the digested DNA on an agarose gel, purify insert with the Gel
extraction kit and quantify the DNA.
5. Ligate with T4 DNA Ligase as in manufacturer’s protocol. Use a
ligation molar ratio from 1:3 to 1:10 (insert:vector).
6. Transform DH5α bacteria with 5 to 10 µl of the ligation product and
plate on agar. Incubate the plates ON at 37 °C
7. Pick single colonies and grow them in LB media plus antibiotics. Purify
DNA by MINIPrep Kit.
8. Quantify and send DNA for sequencing.
6.7. Cell fractionation and protein cross-linking
Reagents as in section 6.4 plus MB Buffer, BMH (0.5 M in DMSO) and
DTT
Materials as in section 6.4 plus Teflon douncer
Procedure:
1. Seed cells (at least 5 15 cm2 dishes for a proper mitochondrial yield)
and follow with protein extraction (steps 1 to 6 of section 6.4)
2. For mitochondrial protein extraction, resuspend cell pellet in MB
Buffer (2 or 4 ml depending on the pellet size) and homogenize in a
Teflon douncer for 100 strokes (check cell integrity by trypan blue dye,
about 70% of the cells should be dyed).
3. Centrifuge samples at 4 °C, 800 x g for 10 min several times with 2 ml
MB Buffer (until no pellet is visible). Save the supernatants of every
centrifugation.
4. Collect all the supernatants and centrifuge at 4 °C 10,000 x g for 10
min to pellet the mitochondrial fraction. Resuspended pellet in MB
Buffer (50 to 200 µl) and centrifuge post-mitochondrial supernatant
at 4 °C, 100000 x g for 60 min to obtain the cytosolic fraction.
5. If no further crosslinking is required, boil mitochondrial and cytosolic
extracts for 5 min in 6x Laemmli Buffer and process for electrophoresis
and western blotting. For cross-linking assay, continue to step 6.
6. Incubate purified mitochondria with BMH (final concentration of 10
mM) at RT for 45 min under gentle agitation. Quench BMH in 0.5 M
DTT in MB Buffer at RT for 15 min. Centrifuge mitochondria at 4
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°C, 9000 x g, resuspend mitochondrial pellet and wash twice in MB
Buffer.
7. Boil mitochondria in 6x Laemmli Buffer and process for electrophoresis
in 10% acrylamide gels and western blotting.
6.8. STED microscopy
Reagents Materials
• PBS
• Cells
• PFA 4%
• Mowiol
• Glass coverslips
• Tweezers
• STED custom-made microscope
Procedure
1. Grow cells on round glass coverslips for 24h to 70-80% confluency,
transfect (see section 6.3) and fix with 4% PFA for 10 min at RT.
2. Wash 3 times with PBS, mount on slides with Mowiol and let them
dry overnight.
3. The specific STED measurements in this work were done as follows:
We used a pulsed diode laser operating at 485 nm and a pulsed
raman fiber laser operating at 560 nm for excitation and stimulated
emission, respectively. The STED beam was spatially formed to a
doughnut by a vortex phase plate. On a longpass filter, both excitation
and STED beam were overlaid and coupled to the microscope stand
(Leica Microsystems, Germany) utilizing an 100x oil objective (1.4NA,
HCX PL APO, Leica Microsystems, Germany). Four galvanometer
mirrors scanned the image field. The fluorescence was separated on a
bandpass filter and guided to a hybrid photodetector. A FPGA-based
software controled the hardware and the data acquisition. Export
of the raw data into tiff-Files and the Gaussian filtering was done
with ImSpectorr Image Acquisition & Analysis Software v0.10 (http:
//www.imspector.de).
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6.9. Fluorescence correlation spectroscopy
(FCS)
Reagents Materials
• Lipids
• Recombinant proteins
• GTPase Buffer
• GTP
• BSA
• Sucrose
• Chloroform
• Ethanol
• Electroformation chamber with
Platinum wires
• Function generator
• Labteck chambers 8-well
• Confocal microscope LSM 710
(Carl Zeiss, Jena, Germany)
with a ConfoCor3 module and a
C-Apochromat 40x, 1.2 N.A.
water immersion objective
• Hardware autocorrelator
Procedure
6.9.1. System calibration
FCS measurements rely on proper alignment and characterization of the
confocal volume. The calibration also serves to compute for the parameters
related to the shape of the detection volume (W0 and S).
S = Wz
W0
(6.1)
D = W
2
0
4τD
(6.2)
A calibration measurement is done with a dye that is spectrally similar to
the fluorophore that will be measured in the membrane and whose diffusion
coefficient (D) is known (e.g. Alexa 488 for GFP).
1. Switch on the lasers around 1 hr before the measurements to allow
stabilization.
2. For dual color FCS, add 200-300 µl of a dilute solution of Alexa 488
and Alexa 633 (approx. 10 nM) to an empty blocked well of a Labteck
chamber and place it under the microscope.
3. Go to FCS tab > Load method (Set up the FCS conFig.uration of
the microscope that best fits the spectral properties of the fluorophore
under study). The optical setup used in this work for dual color 488/633
was: dichroic mirror MBS was set at 488/561/633, beamsplitter at
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575, the filter at the APD1 (red) was set at LP 650 and the APD2
(green) was at 505-540 nm.
4. Adjust laser: select a laser power that gives maximum counts per
molecule without significant photobleaching during the acquisition
time. Depending on the microscope and sample, this is usually around
0.3-1%. Usually start with 0.5 and go lower if you feel there is bleaching.
Focus on the minimum z-value, Go to “count rate” and focus up until
the count rate increases dramatically. Then focus 0.1-0.2 mm above
to make sure we are inside the focal volume (neither on the coverslip,
nor on the surface).
5. Adjust pinhole with respect to the beam path under Lightpath >
Adjust pinhole: set the pinhole to 1 AU. Adjust ch1 and ch2 for X and
for Y. Do a “fine” adjustment, and if there is no peak on the histogram,
adjust on the “course” mode.
6. With the count rate ON, move the correction ring of the objective
without forcing it until the count rate is maximum, to correct for glass
thickness of the observation chamber.
7. Go to Acquisition and set the measurement time to a value 104 longer
than the diffusion time of the dye to have a good aproximation to 0 in
the crosscorrelation curve. Alexa 488’s diffusion time is 15-30 µs, so
measure for at least 10 s. Start measurement.
8. Fit the autocorrelation curve and estimate the diffusion time and the
structure parameter under Fitting. Uncheck repetitions that are erro-
neous (going out-of-focus, with aggregates etc.). Go to the Correlate
tab and select an appropriate model function. For the calibration
samples or other solution samples, use “3D 1 component with triplet”.
Select “Fit All” and evaluate the average of all the curves.
6.9.2. Point FCS
Point FCS is done similar to the calibration measurement, but one has to
adjust the measuring times and repetitions accordingly.
1. Mix the recombinant proteins with GTP (0.1 mM) in GTPase Buffer
to a final volume of 300 µL and add the solution to a blocked well in a
Labteck chamber. Incubate for 15-20 min or heat at 42 °C for 30 min
(only for Bax activation). Place the chamber under the microscope.
The protein concentration used were 50 nM Drp1G, 50 nM BaxR, and
100 or 150 nM Bcl-xLR.
2. Set up measurement. For dyes and small proteins, 60 s may be sufficient.
We do several repetitions (3-5 per well) to make sure that you can
remove a repetition if a big aggregate passes through the confocal
volume.
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6.9.3. sFCS on GUVs (2 focus, 2 color)
1. Clean the electroformation chamber with water and ethanol and let it
dry.
2. Block the wells of a Labteck chamber with 10 mg/ml BSA in PBS for
15 min. Wash with water and GTPase, let it dry for 5 min.
3. Dissolve lipids in chloroform and mix them in the ratio 54: 26: 20 mol
% (DOPC/CL/EggPE , respectively)
4. Evaporate solvent under nitrogen flux and subject to vacuum for at
least 1h.
5. Rehydrate lipid mixtures in chloroform to a final concentration of 2
mg/mL.
6. Take 2.5-3 µl of the lipid stock and spread it on each of the Pt wires
on the side that screws inside the electroformation chamber. Allow
the solvent to evaporate completely.
7. Add 350 µl of 300 mM sucrose solution to each electroformation
chamber. Close the tube with the lid once the lipids are on the wire.
8. Connect the cables of the function generator to each of the two Pt-wires
avoiding contact between them. Apply 10 Hz frequency, 1.5 V, 1h 45
min. (GUV are formed and stick to the platinum wire).
9. Decrease the frequency to 2 Hz, 1.5 V, 30-45 min (GUVs are detached
from the wire).
10. Mix the recombinant proteins (20 nM Drp1G, 50 nM BaxR, 50 nM
Bcl-xLR, and 200-300 nM cBid). with the nucleosides or M-divi1 if
needed in GTPase Buffer to a final volume of 300 µL and add the
solution to a blocked well in a Labteck chamber.
11. Cut the end of a micropipette tip to widen the opening and gently
take the GUV suspension from the electroformation chamber (usually
50-100 µL). Add it on the protein solution and let it incubate for 10-15
min or heat at 42 °C for 30 min (only for Bax activation).
12. Place the chamber under the microscope and adjust the optical setup for
488/633 dual color measurements: dichroic mirror MBS at 488/561/633,
beamsplitter at 575, the filter at the APD1 (red) at LP 650 and the
APD2 (green) at 505-540 nm.
13. Select a GUV (a good size for sFCS is ~20 µm). Be careful, the
detectors are very sensitive, so do not choose the brightest GUVs.
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14. Set up the measurement: Zoom to 6x on the GUV > Save image >
Zoom to 12x on the tangent to the GUV > Set angle to 45° > Scan
and select the equator of the GUV (if possible without aggregates) >
Snap.
15. Choose the following settings: Frame size 32x2, Line step 1, Speed
15, direction unidirectional, 8 bit, Zoom 12 (scan time should then be
1.89 ms), angle 45°> Fix the crop center in the middle of the GUV
equator > Start continuous acquisition.
16. Start the autocorrelator and collect photons for 300 s. Every single
measurement has to be at least 104 times longer than the dye diffusion
time (∼ 30 ms in membranes) to obtain a good aproximation to 0 in
the crosscorrelation curve.
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7Apoptosis imaging in single,mammalian cells
7.1. Optimization of apoptosis visualization
Several factors can affect the timing and progression of apoptosis in mam-
malian cells: type of cell death induction, mitochondrial priming status,
treatment dose, rate of initiator caspases’ cleavage, cell cycle stage, or gene
expression, among others. These factors contribute to a cell-to-cell variability
in the response to apoptosis stimuli. In order to standardize a protocol that
allows the visualization of apoptotic progression in a large number of cells
during a reasonably short time window, we must first determine when cells
start to undergo apoptosis after certain stimuli. To do so, we optimized the
following conditions: cell type, drug type, and treatment dose.
Table 7.1 summarizes the different apoptosis inducers tested (actinomycin
D, etoposide, or staurosporine (STS)). After the addition of the drug, we
recorded time series experiments with a confocal microscope (protocol 6.2).
To rule out cell specific response to the treatments, we used different cell lines
(HeLa, MCF-7, Cos). Although the response to the drugs was heterogeneous
in the cell population, cells started to display apoptotic features one hour
after drug addition (Video 1, HeLa cells after treatment with 1 µM STS, video
starts 45 min after the treatment). Lower concentrations of actinomycin
D did not induce apoptosis until four hours after the stimuli (Fig. 7.1).
However, six hours after the induction, most of the cells were dead in every
condition, as judged by blebbing, round morphology, and detachment from
the surface. These observations indicated that, under the specific conditions
tested, the range between two to six hours after apoptosis induction is the
best time frame to study the molecular events related to this process. The
standard method for apoptosis induction used throughout the experiments
of this thesis was 1 µM STS.
Drug Dose Mechanism of action
Actinomycin D 5 or 10 µg/ml Inhibition of mRNA synthesis
Etoposide 100 µM Blocking of DNA synthesis
CCCP 5 µM Uncoupling of the mitochondrial oxidative
phosphorilation
Staurosporine 1 µM Inhibition of protein kinases
Table 7.1. Drugs and treatment dose used to induce apoptosis
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Figure 7.1. Apoptosis induction. Live cell imaging of HeLa cells treated
with different drugs and dose.
7.2. Bax translocation to the MOM correlates
with mitochondrial depolarization
Bax is a soluble monomeric protein constitutively shuttling between the
cytosol and the mitochondrial surface of healthy cells (Edlich et al., 2011).
Following cell stress, Bax is activated and accumulates at the MOM, where
it undergoes major conformational changes (Lovell et al., 2008), inserts in
the membrane, and oligomerizes to mediate MOM permeabilization (Annis
et al., 2005; García-Sáez et al., 2004). The most accepted model of MOM
permeabilization proposes the formation of Bax pores that allow cytochrome
c and the other apoptotic factors to go through. Recent structural stud-
ies have also shown that active, membrane-embedded Bax arranges into
symmetric dimers, which serve as building blocks for the larger aggregates
that mediate membrane disruption (Bleicken et al., 2010, 2014; Czabotar
et al., 2013; Subburaj et al., 2015). Yet, the supra-molecular arrangement
of Bax in mitochondria during apoptosis and its relationship with MOM
permeabilization remain elusive.
In order to tackle Bax organization in single apoptotic cells via microscopy,
we used the cellular system described in section 7.1 , based on HeLa cells
treated with STS. We transfected the cells with GFP-Bax and stained
them with the membrane potential dependent dye TMRE (protocol 6.3).
This allowed us to track Bax translocation in parallel to mitochondrial
depolarization, and to identify the time point after apoptosis induction when
most of the Bax signal is heterogeneously distributed in discrete foci at the
MOM.
After STS treatment, Bax translocation from the cytosol to the mitochon-
dria was detected by the change from diffuse, cytosolic fluorescence intensity
to a discrete, heterogeneous signal in the green channel (Fig. 7.2a,b, Video
2). We related it with parallel mitochondria depolarization monitored by
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Figure 7.2. Bax translocation correlates with mitochondrial depo-
larozation. (A) Confocal live cell imaging of HeLa cells overexpressing GFP-Bax
(green) and mitochondria stained with TMRE 100 nM (magenta) show cytosolic
GFP-Bax distribution and healthy mitochondria. Lower panels are zoomed images
corresponding to the white rectangle in the upper panel and represent the individ-
ual and merged channels. Time shows the minutes after apoptosis induction with
STS 1 µM. Scale bars, 5 µm (overview) and 2 µm (zooms). (B) HeLa cells shown
in A at longer times after STS treatment. Images show sequential GFP-Bax
translocation (green), which correlates with mitochondria depolarization (TMRE,
magenta). Scale bars, 5 µm. (C) Standard deviation of the fluorescence intensity
of GFP-Bax (blue) versus the corrected total cell fluorescence (CTCF) of TMRE
(purple) in individual cells (N=4). CTCF= Integrated Density – (Area of selected
cell × Mean fluorescence of 3 background readings). Time 0 corresponds to the
normalized time when both events cross in each cell. Black line represents the
average of the individual cells. .
the loss of TMRE fluorescence in the red channel. After two-hour treatment,
cells started to lose their potential and most GFP-Bax appeared translo-
cated to mitochondria, although some cells still retained high mitochondrial
membrane potential even after 4 hours. 6 hours after adding STS, all cells
exhibited a heterogeneous Bax pattern and TMRE fluorescence was not
perceptible any more. We plotted the kinetics of these events for each indi-
vidual cell as the increase in the standard deviation of the GFP fluorescence
intensity, corresponding to Bax translocation to the MOM, against the total
TMRE fluorescence per cell, which indicates mitochondrial potential (Fig.
7.2c). These results indicated that GFP-Bax translocation and mitochondria
depolarization correlate with each other, as expected, and that the most
suitable time frame to study Bax structural organization in apoptosis was
from 2 to 6 hours after the drug treatment.
As a functional control for Bax tagged with GFP, we transfected HeLa cells
with GFP-Bax 1-2/L-6, an inactive Bax mutant that constitutively binds
to mitochondria of healthy cells but does not permeabilize the membrane
(Edlich et al., 2011) (Fig.7.3). This mutant remains in its inactive form but
bound to the membrane due to the presence of a disulfide bond between
Bax helices 1 and 2 and the constriction of the loop between those two
helices to the tip of helix 6. Under control conditions, we detected most
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of GFP-Bax 1-2/L-6 signal at polarized mitochondria, as indicated by the
TMRE fluorescence. This indicates that the MOM remained impermeable
despite the presence of GFP-Bax 1-2/L-6, in contrast to what we observed
with GFP-Bax wild-type. Importantly, this mutant also served as a useful
control in the superresolution studies (protocol 8.1).
GFP-Bax
1-2/L-6
TMRE
Figure 7.3. Bax inactive mutant does not induce membrane depo-
larization. HeLa cells overexpressing GFP-Bax mutant (1-2/L-6) (green) and
mitochondria marked with TMRE 100 nM (magenta). Images show constitutive
GFP-Bax localization to healthy mitochondria without apoptosis induction. Right
panels are zoomed images corresponding to the white rectangle in the left panel
and represent the individual and overlaid channels. Scale bars, 5 µm (overview)
and 2 µm (zooms)
7.3. GFP-Bax is active and oligomerized after
apoptosis induction
The depolarization of mitochondria upon GFP-Bax translocation indicated
that Bax was active under the conditions tested. To rule out potential
overexpression artifacts, we compared the protein expression levels of total
Bax in HeLa cells transfected or not with GFP-Bax and found that they
were very similar (Fig. 7.4a). It seemed that transfected HeLa cells down-
regulated the levels of endogenous Bax so that the total amount of protein
allowed survival. As an additional biochemical control for Bax activation, we
confirmed that the protein was oligomerized by western blot (protocol 6.4).
After cell fractionation and chemical cross-linking, we observed that most of
the Bax signal was localized to the mitochondrial fraction and oligomerized
into dimers and higher oligomers (Fig. 7.4b) (protocol 6.7).
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Figure 7.4. Bax is active and oligomerized in the cells after apoptosis
induction. (A) Analysis of Bax protein levels in HeLa cells (wild-type and
overexpressing GFP-Bax) by Western Blot. The bar graph corresponds to the
quantification of Bax expression in HeLa WT and HeLa GFP-Bax cells. Protein
expression was first corrected with respect to the loading control (actin). Then,
the expression of endogenous Bax from WT cells was normalized to 100% and
compared with the total amount Bax (arising from endogenous protein and GFP-
Bax) in transfected cells. (B) Analysis of Bax translocation and oligomerization
in the mitochondrial fraction by Western Blot. VDAC, loading control.
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8 Super-resolution of Baxduring apoptosis
8.1. Supramolecular strcuture of Bax oligomers
in apoptotic cells: Single-molecule
localization microscopy
Confocal live cell imaging revealed that GFP-Bax translocates to discrete
foci after an apoptotic insult, presumably at mitochondria (see section 7.2).
However, this technique does not have enough resolution to distinguish the
shape of such clusters. To investigate the nanoscale organization of Bax
oligomers during apoptosis, we used single molecule localization microscopy
(SMLM).
We labeled HeLa cells overexpressing GFP-Bax with anti-GFP nanobodies
coupled to Alexa Fluor 647 (Af647), a fluorescent probe optimized for super-
resolution imaging (protocol 6.5) (Ries et al., 2012). These nanobodies are
smaller than usual antibodies (1.5 nm x 2.5 nm) and bind GFP with high
specificity (Rothbauer et al., 2006).
We acquired images on fixed cells that had been treated with STS for
2-6 hours and qualitatively showed no difference in the number or shape of
structures within this range of incubation times with the drug. In particular,
the individual cells selected for imaging in the different experiments exhibited
a similar apoptotic state, characterized by GFP-Bax in a dotted distribution,
but overall cellular integrity, as judged by the cell shape and the absence of
blebs (Fig. 8.1, 8.2a). This was important to minimize the background signal
of cytosolic Bax because it would interfere with a proper image reconstruction.
Therefore we visualized a specific apoptotic stage corresponding to the
organization of Bax signal once almost all molecules are irreversibly bound
to mitochondria, but before most cellular components have been disassembled.
As the pores induced by Bax are stable and permeabilize mitochondria for
long periods of time (Bleicken et al., 2013; Muñoz-Pinedo et al., 2006), the
stage of Bax organization we investigated was associated with the pore-
forming state of Bax oligomers.
Reconstructed super-resolution images showed a large fraction of the Bax
signal as random dots or big aggregates in which no particular structural
organization could be distinguished. Strikingly, we also found a significant
amount of well-defined non-random structures (Fig. 8.2b,c). Concretely, we
identified both full and incomplete (arc-shaped) rings of Bax molecules, as
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Figure 8.1. Cell shape outlined in super-resolution SMLM. (A) Bright
field images and SMLM overviews of HeLa cells overexpressing GFP-Bax or GFP-
Bax 1-2/L-6, respectively. Bright field images were taken in the GFP and AF647
channels before acquisition with single molecule localization. Scale bars, 500 nm.
(B) SMLM images shown in A, reconstructed with all the localizations and no
cut-off applied. Pictures were converted to binary images and a black-white mask
was applied to define the cell shape. Scale bars, 500nm.
well as linear assemblies, which in a few cases appeared as double lines (Fig.
8.2c).
In an effort to validate the connection between these defined structures
and Bax role in MOM permeabilization, we examined the signal of inactive
Bax at mitochondria under control conditions by SMLM. We acquired super-
resolution images of healthy HeLa cells transfected with the non-functional
mutant GFP-Bax 1-2/L-6 (Figs. 8.1, 8.3). Consistent with the lack of
activity, we detected a higher proportion of undefined dots and aggregates
in GFP-Bax 1-2/L-6 with respect to its wild type counterpart (GFP-Bax
WT), which were in general smaller. To ensure a systematic, blind analysis,
we also classified the non-random structures as lines, arcs and full rings (we
did not detect any double lines).
8.2. Quantification of GFP-Bax assemblies
8.2.1. Size of the assemblies
In order to compare quantitatively the GFP-Bax assemblies observed via
SMLM under apoptotic and healthy conditions, we next counted the total
number of structures observed by SMLM in the GFP-BaxWT and GFP-Bax
1-2/L-6 samples. Consistent with the lack of activity of the mutant, we
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Figure 8.2. SMLM reveals non-random Bax structures during apop-
tosis. (A) Overview of a reconstructed superresolution image of GFP-Bax overex-
pressing HeLa cells stained with AF647-anti-GFP-nanobodies. Image was acquired
on fixed cells 3 h after apoptosis induction with STS. Dotted line shows the cell
shape. Scale bar, 5 µm. (B) Magnified reconstructed superresolution image
corresponding to the white rectangle in A showing the shapes of GFP-Bax WT
structures (white arrows). Scale bar, 500 nm. (C) Gallery of typical GFP-Bax
WT structures during apoptosis found in all the analyzed cells. Scale bars, 100
nm.
detected a higher proportion of undefined dots and aggregates in GFP-Bax
1-2/L-6 with respect to its wild type counterpart (GFP-Bax WT) (Fig. 8.4).
We then calculated different parameters for each type of structure. Con-
cretely, we measured: i) the area of dots and aggregates, ii) the length of the
lines, iii) the length and the radius of curvature of the arc assemblies and iv)
the radius of the full rings (Fig. 8.5). Although the number of clear complete
rings of GFP-Bax WT molecules was lower than that of other structures,
they were almost absent in the inactive mutant, which strongly supports
their functional character (Fig. 8.4, Fig. 8.5a). Their radius followed a
normal distribution centered on a diameter of 35 nm, in good agreement
with Bax pores observed in liposomes (Bleicken et al., 2010). In the case of
arc-shaped assemblies, their length was broadly distributed and two peaks at
approximately 100-300 nm and 400-500 nm could be distinguished for GFP-
Bax WT (Fig.8.5b,c). Linear structures also followed a wide distribution
in GFP-Bax WT samples with lengths centered at 200-250 nm (Fig. 8.5d).
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Figure 8.3. Bax inactive mutant displays random structures. Overview
(top) and 3 enlarged insets (bottom) of HeLa cells overexpressing GFP-Bax 1-
2/L-6 stained with AF647-anti-GFP-nanobodies. Figure shows reconstructed
super-resolution images acquired without apoptosis induction. Scale bars, 5 µm
(overview) and 500 nm (insets).
In contrast, the inactive mutant exhibited less and shorter arcs and lines
(Fig. 8.5b-d). In agreement with Bax oligomerization during apoptosis, the
undefined structures were also larger for GFP-Bax WT than for GFP-Bax
1-2/L-6 (Fig. 8.5e-f). In summary, these differences in the signal suggest
that the defined structures detected in GFP-Bax WT are distinct from those
of the inactive mutant and confirm that they are related to the functional
role of Bax in MOM permeabilization during apoptosis.
8.2.2. Distribution of Bax assemblies among the cells
Our quantification involved the total number of structures found in all
measured cells together, but it is also important to consider cell-to-cell het-
erogeneity. To account for this, single cell cumulative distribution functions
were plotted. As shown in Fig. 8.6, mutant GFP-Bax 1-2/L-6 overex-
pressing cells displayed in all cases considerably smaller structures than the
active protein. Besides, the cumulative distribution functions of individual
cells corresponding to WT or mutant GFP-Bax were similar and could
be distinguished as two different populations. These results confirm that
the structures analyzed in the images of WT and mutant GFP-Bax are
significantly different from each other and comparable in the different cells
analyzed for each of them.
In the case of GFP-Bax structures organized as two lines or arcs parallel
to each other (Fig. 8.2c), we cannot discard their possible relevance in
the molecular mechanism of Bax function at the MOM despite their low
numbers. They have a defined shape and their size is comparable to the
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Figure 8.4. Bax inactive mutant shows more random structures. Fre-
quency of the different types of Bax assemblies in HeLa cells with respect to the
total number of assemblies found in each condition (GFP-Bax WT or GFP-Bax
mutant 1-2/L-6).
single lines. Indeed, these double structures, only detected in GFP-Bax
WT images, resembled the spiral assemblies proposed for the dynamin-like
protein Drp1 during mitochondrial fragmentation (Mears et al., 2011).
8.3. GFP-Bax organization in Bax/Bak DKO
cells
To rule out potential effects due to the presence of endogenous Bax and
Bak in HeLa cells transfected with GFP-Bax, we also performed SMLM
experiments in Bax/Bak double knock out (DKO) HCT116 cells transfected
with GFP-Bax. Fig. 8.7 shows that untransfected cells had no expression of
Bax at the protein level. In this different cellular background, these cells
needed longer incubation times with the apoptotic drug than HeLa cells in
order to show heterogeneous GFP-Bax distribution. After fixing the cells at
different times following STS treatment, we observed that 7h was the best
time point to analyze GFP-Bax structures by SMLM in HCT116 Bax/Bak
DKO cells. In the absence of endogenous protein, we could also identify
a significant fraction of non-random GFP-Bax structures including lines,
double lines, arcs and full rings of comparable sizes (Fig. 8.7b,c).
8.4. STED microscopy reveals similar structures
of Bax during apoptosis
In order to corroborate that the results of SMLM were not dependent on the
sample preparation or imaging technique, we directly measured GFP-Bax
distribution (without staining with nanobodies) during apoptosis with an al-
ternative super-resolution method, stimulated emission depletion microscopy
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Figure 8.5. Bax wild type adopts different organization from the
inactive mutant. (A-F) Histograms show the number and size of the structures
found on GFP-Bax WT (purple) and on GFP-Bax 1-2/L-6 (grey) overexpressing
cells. Data show the total number of structures in all the measurements. n (Bax
WT)= 13, n (Bax 1-2/L-6)=11.
(STED) (Protocol 6.8). This technique has also showed improvements in
resolution up to 60 nm for imaging of GFP labeled molecules (Willig et al.,
2006; Rankin et al., 2011).
Fig. 8.8 depicts a substantial resolution increase in the STED pictures
compared to those acquired with diffraction limited imaging. This technique
also revealed comparable non-random assemblies of GFP-Bax shaped as
lines, arcs, rings and even double lines (Fig. 8.8b), supporting that the
structures characterized with localization microscopy reflect the organization
of Bax in apoptotic mitochondria.
As an additional control, we measured the distribution of other mitochon-
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Figure 8.6. Distribution of GFP-Bax structures in each cell displays
two different population. Cumulative distribution plots of GFP-Bax wild
type (purple) and GFP-Bax 1-2/L-6 (grey) showing differences in amplitude
and frequency. Each plot represents a single cell. Thick lines represent average
cumulative distributions for all the single cells overexpressing GFP-Bax WT or
mutant GFP-Bax 1-2/L-6.
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Figure 8.7. GFP-Bax non-random structures are not affected by en-
dogenous Bax. (A) Analysis of Bax protein levels in HCT116 Bax/Bak DKO
cells (wild-type and overexpressing GFP-Bax) by Western Blot. (B) Overview
of a reconstructed superresolution image of GFP-Bax overexpressing HCT116
Bax/Bak DKO cells stained with AF647-anti-GFP-nanobodies Image was ac-
quired on fixed cells 7 h after apoptosis induction with STS. Dotted line shows
the cell shape. Scale bar, 5 µm. (C) Gallery of typical GFP-Bax WT non-random
structures during apoptosis on HCT116 Bax/Bak -/- cells. Scale bars, 100 nm.
drial proteins with STED, concretely GFP-TOM20 and GFP-MitoNEET.
As shown in Fig. 8.8c and d, the resolution also increased considerably with
STED, but the distribution of these proteins differed from that of GFP-Bax.
This indicated that the non-random assemblies detected for Bax were not a
common organization of constitutive mitochondrial proteins.
8.5. Bax shows a heterogeneous distribution at
mitochondrial foci during apoptosis
Previous studies have shown that mitochondria undergo massive fragmen-
tation upon apoptosis induction and that Bax localizes at the specific foci
where this process takes place (Karbowski et al., 2002).
To determine the position and orientation of GFP-Bax structures on the
MOM, we carried out dual color confocal and super-resolution experiments.
We first performed time series confocal imaging on HeLa cells co-transfected
with GFP-Bax and mito-dsRED (mitochondrial marker) following STS treat-
ment. After approximately one hour, GFP-Bax started to accumulate at
discrete sites at mitochondria (Fig. 8.9). This Figure (panel b) also il-
lustrates that GFP-Bax localized specifically at mitochondrial tips after
apoptosis induction (Videos 3-6).
However, confocal microscopy cannot provide information about the struc-
ture or orientation of Bax assemblies on the membrane at the nanoscale.
For this reason, we performed two-color SMLM on HeLa cells transfected
with GFP-Bax, which were immunostained 3 hours after apoptosis induction
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Figure 8.8. Bax non-random structures revealed by STED. (A) Com-
parison of confocal (left) and STED (right) images of GFP-Bax overexpressing
HeLa cells 2h after STS treatment. STED reveals a notable increase in resolution.
Scale bars, 500 nm. (D) Representative GFP-Bax non-random structures found
with STED (lines, arcs, rings, double lines). Scale bars, 100 nm. (C-D) Compari-
son of confocal (left) and STED (right) images of HeLa cells overexpressing the
mitochondrial proteins GFP-MitoNEET or GFP-Tom20 2h after STS treatment.
with AF647–anti-GFP nanobodies for Bax signal and CoxIV antibody (with
CF680 as secondary antibody) as a mitochondrial marker (Fig. 8.10a). As
an alternative to CoxIV imaging, we co-transfected the cells with mMAPLE-
mito, a photo-switchable fluorescent protein suitable for SMLM that acted
as mitochondrial marker (Fig. 8.10b). The images qualitatively showed all
GFP-Bax signal heterogeneously distributed in discrete foci on mitochondria
in both cases, as expected. In particular, it localized along the mitochondrial
tubules as well as on mitochondrial ends. Non-random arrangements corre-
sponding to Bax assemblies could be distinguished in structures wrapping
mitochondria, in addition to dots and aggregates (Fig. 8.10). When we
examined if the distribution of the non-random assemblies of GFP-Bax were
detected preferentially at specific sites along the mitochondrial network, we
did not observe any clear preference.
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Figure 8.9. Confocal microscopy: Bax localizes to discrete mitochon-
drial foci during apoptosis. (A) Left panel shows the individual channels
and overlaid images of confocal live cell imaging of HeLa cells overexpressing
GFP-Bax (green) and mito-dsRed (magenta) at 0 and 85 minutes after apoptosis
induction with STS 1µM. Scale bars, 10 µm. (B) Zoomed overlaid images of HeLa
cells following GFP-Bax translocation (green) and mitochondrial fragmentation
(magenta) during apoptosis induction with STS 1 µM. See also Videos 3 to 6.
Scale bars, 2 µm.
8.6. MOM pores observed by electron
microscopy
So far the existence of pores on the mitochondria of apoptotic mammalian
cells has not been reported in the literature. In order to check if the
presence of non-random Bax structures correlated with the opening of pores
at the MOM, we analyzed the mitochondria of HeLa cells transfected or not
with GFP-Bax using transmission electron microscopy (Fig. 8.11a). The
embedding and imaging of the cells were done by the Electron Microscopy
Core Facility at the University of Tübingen.
After 3h treatment with STS, cells presented the typical apoptotic phe-
notype with swollen endoplasmic reticulum and reorganized mitochondrial
cristae. In both cases, we detected events of MOM disruption, which exhib-
ited sizes in the same order of magnitude as the Bax structures identified in
the superresolution images. These pores or defects were absent in the MOM
of control healthy HeLa cells.
Additionally, we aimed to correlate the localization of GFP-Bax with the
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Figure 8.10. Super-reolution SMLM: Bax non-random structures at
apoptotic mitochondria. (A) Reconstructed dual-color superresolution image
of GFP-Bax overexpressing HeLa cells immunosstained with Af647-anti-GFP-
nanobodies and with CoxIV (primary) and CF680 (secondary) antibodies (used as
a mitochondria staining). Image was acquired 3h after STS treatment. Left panel
shows the cell overview (scale bar, 5 µm), right panel up shows the overview inset
(scale bar, 500 nm) and right panel down shows a non-random linear GFP-Bax
assembly at mitochondria (scale bar, 100 nm). (B) Reconstructed dual-color
superresolution image of HeLa cells co-overexpressing mMaple-mito and GFP-
Bax and stained with Af647-anti-GFP-nanobodies. Image was acquired 3h after
STS treatment. Lower panel shows enlarged insets corresponding to the white
rectangles in the upper panel. Scale bars, 1 µm (overview) and 100 nm (insets)
pores on the MOM. For that, we used Mini-SOGs (mini Singlet Oxygen
Generator) tagged to GFP-Bax, a label for correlated light and electron
microscopy. Although the Mini-SOG precipitates were too big to discern if
Bax was delineating the MOM openings, we could observe that GFP-Bax
Mini-SOG acumulated selectively on apoptotic mitochondria, while healthy
mitochondria did not show large Mini-SOG precipitates (Fig. 8.11b). These
results provide another indication about Bax translocation and specific
localization at apoptotic mitochondrial foci.
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2 µm
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Control Apoptosis
Figure 8.11. Transmission electron microscopy reveals MOM open-
ings in apopotic mitochondria. (A-C) Representative TEM pictures of HeLa
wild-type and GFP-Bax overepressing cells with and without STS treatment (1
µM). Scale bars, 500 nm (overview) and 200 nm (zooms). (C) Representative
TEM pictures of HeLa GFP-Bax-miniSOG overexpressing cells (control and 4 h
after STS treatment. Blue arrowheads point to miniSOG precipitates. Scale bars,
500 nm.
8.7. AFM demonstrates that full rings and
arc-shaped assemblies of Bax perforate the
membrane
To investigate if the oligomeric arrangements of Bax detected in apoptotic
cells by super-resolution microscopy were related to pore formation, we
performed experiments of atomic force microscopy (AFM). In addition to
a high spatial resolution, this technique also provides information about
the 3D topography of the membrane surface. The AFM experiments were
performed by a colleague, Dr. Katia Cosentino. For this purpose, we
prepared supported lipid bilayers from proteoliposomes containing activated,
membrane-bound Bax and we analyzed them with AFM. In contrast to
control samples, which exhibited largely flat membranes with few defects,
the supported lipid bilayers containing activated Bax were rich in structures
protruding 3.97 ± 1.02 nm from the membrane plane that corresponded most
likely to Bax clusters (Fig. 8.12a,b). Interestingly, the higher structures in
the samples with Bax had the same structural organization as the GFP-Bax
clusters in the SMLM experiments, and were also heterogeneous in size
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Arcs (radius) Lines (length) Rings (radius)
SMLM 73±30 214±80 34±7
AFM 86±40 249±110 32±4
Table 8.1. Size comparison of Bax non-random structures between
SMLM and AFM. Units in nm
and shape. They also included lines, rings and arc-shaped arrangements of
protein in addition to random dots and aggregates.
For consistency, we performed the same analysis of the AFM images
for the non-random assemblies as with the super-resolution images. As
shown in Fig. 8.12d and Table 8.1, not only the size of the structures
but also their distribution were in very good agreement with the SMLM
results (Fig. 8.5). This strongly suggests that the defined architectures
detected in both cases were alike. Importantly, we were able to visualize
membrane pores associated with defined structures in the samples containing
Bax (Fig. 8.12a,b). These pores were also heterogeneous in size and shape,
but generally round with diameters ranging from around 24 to 176 nm and
appeared as steep depressions of 3.85 ± 0.47 nm with respect to the flat
surface of the lipid bilayer, which fits well with the membrane thickness.
They were characterized by the presence of higher structures, congruent with
Bax molecules distributed along the pore rim. Concretely, 97% of complete
rings that we could resolve contained a pore in the interior. In the case of
arc-shaped assemblies, 12% of them were also associated with membrane
pores, where Bax molecules covered only a fraction of the pore rim and the
rest corresponded to naked lipid bilayer. These results provided a functional
link to the non-random Bax structures.
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Figure 8.12. Full rings and arcs of Bax are associated with mem-
brane pores. (A) AFM image of a control SLB prepared from LUVs with a
mitochondrial-like lipid composition. The bilayer looks flat, without aggregates or
defects. Scale bar, 1 µm. (B) AFM image of a SLB prepared from LUVs with a
mitochondrial-like lipid composition pre-incubated with heat-activated Bax. The
green arrows indicate the presence of membrane pores, which are heterogeneous in
size and shape. The edges of the pores present protrusions corresponding to Bax
clusters. Scale bar, 1 µm. (C) 3D AFM topography of a Bax arc (left) and ring
(right). Both images reveal a circular dark hole that spans the lipid membrane
(green). Bax molecules around the pore rim (magenta and white) protrude 3.97
± 1.02 nm above the membrane plane, as confirmed by the height profiles shown
below each image (corresponding to the white line in the 2D image insets). The
topography of the arc structure reveals a pore only partially surrounded by Bax
molecules, while lipids alone form the rest of the pore rim. Images are shown in a
42 °C tilted representation. (D) Quantitative analysis of the distinct structures
found for activated Bax on SLBs. Data show the total number of structures in all
the measurements. If not differently specified, the scale bar in all the images is
100 nm.
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9 Interplay between Drp1 andBcl-2 proteins
9.1. Dual-color single-molecule localization
microscopy: colocalization of Bax and Drp1
at mitochondrial foci during apoptosis
Several studies have proposed a functional interplay between the Bax and
Drp1 when they promote MOM permeabilization and mitochondrial frag-
mentation during apoptosis (Montessuit et al., 2010; Frank et al., 2001).
Moreover, Bax and Drp1 have been shown to colocalize at the same dis-
crete foci on the mitochondria of apoptotic cells using confocal imaging
(Karbowski et al., 2002; Wasiak et al., 2007). However, the resolution limit
of ∼200 nm in traditional optical microscopy does not allow one to know
if, at the molecular level, both proteins are in contact, organizing next to
each other or several nanometers apart, for example forming part of a larger
supramolecular structure formed at the mitochondrial foci.
In order to check if the non-random assemblies of Bax indeed correlated
with Drp1 distribution on mitochondria also at the nanoscale, we investigated
the distance between Drp1 and GFP-Bax structures during apoptosis by two-
color SMLM. Endogenous Drp1 was tagged with anti-Drp1-cf680 antibodies
in HeLa cells overexpressing GFP-Bax, which was labeled with AF647–anti-
GFP nanobodies after STS treatment. As shown in Fig. 9.1a, Drp1 is also
heterogeneously distributed in a dotted manner within the cell, presumably
at mitochondria. Moreover, we could also observe non-random structures of
Drp1 (Fig. 9.1b). However, we could not detect as many of them as with
GFP-Bax, probably due to the lower labeling densities achieved with the
conventional anti-Drp1 antibody.
As expected, most of Drp1 structures appeared together with or next
to GFP-Bax. Here it is important to note that, unlike with traditional
fluorescence microscopy, the resolution limit is in the order of the molecular
size of the structures analyzed and as a consequence, colocalizing signals
often do not appear superimposed to each other. Therefore, to analyze how
close the two proteins were and if there was a trend for them to be placed next
to each other, we calculated the distance between all the detected GFP-Bax
and Drp1 structures that had more than 100 localizations (to ensure that
they did not correspond to arbitrary single antibodies). We chose a threshold
for colocalization at 30nm, due to the limit in resolution of SMLM. Taking
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Figure 9.1. Dual color single molecule localization does not reveal a
significant separation between Bax and Drp1. (A) Reconstructed dual
super-resolution image of GFP-Bax WT overexpressing HeLa cells stained with
AF647-anti-GFP-nanobodies and Drp1 cf680 antibody. Image was acquired 3 h
after STS treatment. Scale bar, 2 µm (B) Magnified reconstructed superresolution
images show GFP-Bax WT and Drp1 assemblies close to each other during
apoptosis. Scale bar, 100 nm (C) Quantification of the distances between GFP-
Bax WT and Drp1 structures on SMLM.
this into account, approximately 80% of the Bax/Drp1 signal was located
less 30 nm apart, 20% of the structures were positioned at distance from
30 to 80 nm and only 5% were more than 80 nm apart. Altogether, these
observations showed that, within a spatial resolution of 30 nm, GFP-Bax
and Drp1 assemblies colocalized on the surface of apoptotic mitochondria.
Considering the size of the resolved spot and that both proteins are forming
high order oligomers, likely of the order of tens of nanometers each, these
results also suggest that, under the conditions studied, Bax and Drp1 are
very close if not in direct contact with each other.
9.2. FCCS: Drp1 binding to Bax and Bcl-xL
9.2.1. Bax and Drp1 interact in lipid membranes
To check if there is direct binding between Bax and Drp1, we used a cell-
free reconstituted system with purified recombinant proteins, fluorescently
labeled with Atto488 (Drp1G) or Alexa633 (BaxR). Then, we examined if
these two proteins can directly interact by using FCCS in solution and in
the membrane of giant unilamellar vesicles (GUVs).
GUVs are lipid vesicles of several micrometers in diameter that can be
directly visualized by optical microscopy. sFCS can be applied on these
liposomes, which makes them a very helpful system to study potein/protein
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Figure 9.2. Drp1 interacts with Bax in lipid membranes. (A) Repre-
sentative auto- and cross-correlation analysis of solution FCCS between Drp1G,
BaxR. (B) Representative auto- and cross-correlation analysis of sFCCS between
Drp1G, BaxR in the membrane of GUVs. Dash gray lines depict raw data. (C)
Box plot for the percentage of cross-correlation measured between Drp1G and
BaxR in solution, in membrane, and in membrane with the presence of an excess
of unlabeled cBid. GUV composition was DOPC:CL:PE (54:26:20) . (D) Diffusion
coefficients calculated for Bax and Drp1 in the complex (C) and alone (A) in
solution. (E) Diffusion coefficients calculated for Bax and Drp1 in the complex in
GUVs.
interactions in membranes. We activated Bax by mild heat (42 ◦C) and in-
cluded 0.1 mM GTP in the protein mixture to enhance Drp1 oligomerization
and mimic its physiological function in mitochondrial fission.
In solution, point FCCS measurements gave rise to the autocorrelation
curves in Fig. 9.2a, but no positive cross-correlation was observed, indicating
that Bax and Drp1 do not associate in the aqueous environment.
Both proteins exert their main function when they insert in the mitochon-
drial membrane, where they are in an active, oligomerized conformation. To
check the active role of the lipid membrane in Bax-Drp1 complex formation,
we measured two-color two-focus scanning FCS (sFCCS) in giant unilamellar
vesicles (GUVs). We added Drp1G, BaxR, and GTP to a suspension of GUVs
composed by 1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC), heart cardi-
olipin (CL), and Egg L-α-phosphatidylethanolamine (PE) (54:26:20). After
30 min incubation at 42 °C, we measured sFCS in single GUVs containing
the bound proteins, specifically across the vesicle equator. As shown in (Fig.
9.2b), Drp1G and BaxR formed complexes in lipid membranes, as seen by
the positive amplitude of the cross-correlation curve. We detected a broad
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Figure 9.3. Drp1 induces vesicle tubes and tethering, colocalizing
with Bax and Bcl-xL. (A) Representative GUV with bound Drp1G (green)
and BaxR (magenta). White regions represent colocalization. (B) Representative
GUV with bound Drp1G (green) and Bcl-xLR (magenta).
distribution of cross-correlation percentages (21±14%, ±s.d.), which likely
indicates heterogeneities in the extent of association in the different GUVs
(Fig. 9.2c. From the respective autocorrelation curves, we calculated the
diffusion coefficients for both proteins. In solution, Drp1 clearly diffused
slower than Bax (69±9 and 122±5 µm2s−1, respectively) but the diffusion
coefficients measured in the samples with the presence of both proteins was
very similar to that of the protein alone in solution (99±2 µm2s−1 for Bax
and 68±3 µm2s−1 for Drp1), in line with the lack of complex formation in
the aqueous environment (Fig. 9.2d). When Bax and Drp1 were forming
complexes in membranes, we calculated diffusion coefficient that were one
order of magnitude slower (4±1 µm2s−1 for Bax and 3±1 µm2s−1 for Drp1),
as expected (Fig. 9.2e).
Importantly, we could observe that Drp1 binding to the GUVs induced
tubulation and vesicle tethering, as expected. Bax colocalized partially with
Drp1 in the GUVs. It bound extensively to the same regions of vesicle
tethering as Drp1, but only faintly to the tubes (Fig. 9.3a).
Bax activation is regulated by the BH3-only protein Bid. In the presence
of cleaved Bid (cBid), Bax exhibits pore fomation in vitro without altering
vesicle integrity. Strikingly, cBid-induced Bax oligomerization is enhanced
by Drp1 (Montessuit et al., 2010). To evaluate if cBid could affect Drp1-Bax
interactions in membranes, we added an excess of non-fluorescent cBid to the
GUV mixture containing Drp1G and BaxR. Strikingly, as shown in Fig. 9.2c,
cBid addition lead to a decrease in the cross-correlation from an average
of 21±14 % to 8±4 %. These results indicate that cBid competes for the
interaction between Drp1G and BaxR, or that cBid-induced Bax activation
alternatively precludes interaction.
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9.2.2. Drp1 interacts with Bcl-xL
The anti-apoptotic protein Bcl-xL inhibits Bax activation and disrupts Bax
homo-oligomers (Antonsson, 2001; Subburaj et al., 2015). If membrane
remodeling by Drp1 helps Bax oligomerization and Bcl-xL disrupts the
oligomers, we wondered if Bcl-xL may also form complexes with Drp1. To
check this, we incubated Bcl-xL labeled with Alexa 647 (Bcl-xLR ) and
Drp1G with a mixture of GUVs composed by DOPC:CL:PE (54:26:20).
Interestingly, in this case the proteins did not need to be previously
activated to bind to the GUVs, and we observed that both proteins colocalized
on the Drp1-induced tubes as well as at the tethering regions (Fig. 9.3b).
These observations suggest that Drp1 and Bcl-xL induce each other’s binding
to membranes. In order to detect interactions in vitro, we measured FCCS
in solution and in membranes between Drp1G and Bcl-xLR. After 15 min
incubation at room temperature, we could already detect cross-correlation
between Drp1G and Bcl-xLR in solution (Fig. 9.4a). sFCCS measurements
revealed that Drp1G and Bcl-xLR also interacted in membranes, with a similar
percentage as in solution (20±9 % in solution and 19±9% in membranes).
We deduced diffusion coefficients in solution of 30±9 µm2s−1 (Bcl-xLR)
and of 27±9 µm2s−1 (Drp1G) (Fig. 9.4b). Both proteins diffused slower
compared to the individual proteins (68±3 µm2s−1 for Drp1 and 86±5
µm2s−1for Bcl-xL). As the diffusion coefficient depends on the hydrodynamic
radius of the proteins, this decrease in mobility indicates that both proteins
were forming a bigger complex under these conditions. The mean diffusion
coefficient of Drp1G and Bcl-xLR in membranes was 4±1 µm2s−1 (Fig. 9.4c),
in line with previous work (Bleicken et al., 2013; García-Sáez et al., 2009). In
this case, the diffusion coefficients between the proteins in the complex and
alone were similar. This weak effect is explained by the fact that the diffusion
coefficient in the two-dimensional membrane is related to the logarithm of
the protein’s hydrodynamic radius.
As with Bax, addition of an excess of non-fluorescent cBid led to a decrease
in cross-correlation between Drp1G and Bcl-xLR in membranes to 8±6 %.
These data not only pinpoint a direct interaction between Drp1G -Bcl-xLR,
but also show that the complex can be disrupted by cBid at the membrane
level.
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Figure 9.4. Drp1 interacts with Bcl-xL in solution and in membranes.
(A) Representative auto- and cross-correlation analysis of solution FCCS between
Drp1G, Bcl-xLR. (B) Representative auto- and cross-correlation analysis of sFCCS
between Drp1G, BaxR in the membrane of GUVs. Dash gray lines depict raw data.
(C) Box plot for the percentage of cross-correlation measured between Drp1G
and Bcl-xLR in solution, in membrane, and in membrane with the presence of
an excess of unlabeled cBid. GUV composition was DOPC:CL:PE (54:26:20).
(D) Diffusion coefficients calculated for Bcl-xL and Drp1 in the complex (C) and
alone (A) in solution. (E) Diffusion coefficients calculated for Bax and Drp1 in
the complex in GUVs.
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10Discussion
In this thesis, we have characterized the supramolecular organization of active
Bax oligomers involved in mitochondrial outer membrane permeabilization
during apoptosis. We provide the first single and dual-color superresolution
microscopy study of a Bcl-2 homolog in single cells to yield insight into
the organization of the pro-apoptotic protein Bax in mitochondria and its
association with a fission mediator protein, Drp1. The work is complemented
with in vitro single-molecule studies on the characterization of this interplay.
10.1. Bax assembly into rings and arcs in
apoptotic mitochondria is linked to
membrane pores
This work reports the assembly of Bax oligomers into a distribution of rings
and arc-shaped structures in the mitochondria of apoptotic mammalian
cells. Based on the ability of these structures to form pores in pure lipid
bilayers, we propose a new molecular mechanism for Bax-mediated MOM
permeabilization during apoptosis (Salvador-Gallego et al., 2016).
The cellular distribution of Bax is dynamic. In healthy cells, the protein
is diffusely located in the cytosol. Upon apoptosis induction, homogeneous
Bax signal appears initially at the MOM, which then evolves into discrete
mitochondrial foci that correlate with loss of mitochondrial potential, while
still coexisting with cytosolic protein. This is in line with previous work
that suggested that in single cells only minimal gathering of Bax is needed
to burst mitochondria depolarization and fragmentation (Düssmann et al.,
2010). In the final steps, total translocation of Bax to the MOM is achieved
(Zhou and Chang, 2008).
We have studied the supra-molecular structure of active Bax in apoptotic
cells by two superresolution techniques, SMLM and STED. In SMLM, only a
portion of the fluorophores are stochastically activated at the same time and
then precisely localized. After the accurate localization of all the molecules,
the superresolution image can be reconstructed. The working principle of
STED is different from SMLM: it is based on the overlay of a diffraction-
limited spot with a doughnut-shaped laser which depletes the fluorescence
everywhere in the focal region but in the very center of the spot (Hell and
Wichmann, 1994). As a result, the fluorescence emission is confined to a
very small region.
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Figure 10.1. (A) Illustration of the possible roles for the Bax non-random
assemblies revealed by SMLM and AFM during apoptosis. Linear and arc clusters
not perforating the membrane could correspond to Bax at initial stages of gathering
on healthy mitochondria. They would evolve towards opening of membrane pores,
where the protein is covering completely (full rings) or partially (arcs) the pore
rim. We cannot exclude that a fraction of the linear and arc-shaped assemblies
correspond to Bax pores observed from different perspectives. The number of red
spheres (Bax dimers) is illustrative and does not need to correlate with the actual
number present in the structures. (B) The mechanism by which Bax permeabilizes
the membrane is mainly by releasing the curvature stress at the membrane edge.
Full as well as partial coverage of the pore rim by Bax molecules could reduce
line tension enough to stabilize the open pore state. The illustration shows an
incomplete ring assembly of active Bax dimers adopting a clamp-like structure at
the pore interface (Bleicken et al., 2014).
To achieve the best performance with SMLM, we minimized the back-
ground cytosolic GFP-Bax signal to optimize the contrast of GFP-Bax signal
at mitochondria and subsequent image reconstruction. Thus, we visualized
a specific apoptotic stage, when Bax had completely translocated to the
MOM, induced loss of mitochondrial potential and, presumably, release of
cytochrome c, but before cells rounded-up as a result of the dismantling of
the cellular components due to caspase activity.
The SMLM superresolution microscopy data showed a significant fraction
of GFP-Bax signal localized at discrete foci along mitochondria and organized
into distinct architectures, classified as full rings, arcs and lines. These were
characterized by a wide distribution of sizes, with rings in the order of
50 to 100 nm in diameter. Moreover, we detected comparable structural
arrangements of activated Bax using STED microscopy in apoptotic cells
and in supported lipid bilayers using AFM imaging.
Importantly, the physiological relevance of the Bax structures reported
here is sustained by the differences in assembly observed for the inactive
mutant GFP-Bax 1-2/L-6, which is constitutively located at the MOM of
healthy cells. Although confocal microscopy gives rise to similar images
when transfecting both constructs, the differences become prominent when
the structures are analyzed by SMLM. Aggregates and dots are considerably
smaller, in good agreement with the lower tendency of the mutant version
of GFP-Bax to oligomerize. In addition, the lower amount of non-random
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structures detected reflects the tendency of WT GFP-Bax to arrange into
specific assemblies, in contrast with the mutant.
The assembly of GFP-Bax into full as well as incomplete rings at the
MOM reported here supports a molecular mechanism in which the pore
structures formed by Bax in apoptotic mitochondria are lined by both lipids
and proteins, where the latter may or not cover the full pore rim (Fig. 10.1a).
The AFM images confirmed this pore formation hypothesis, showing that
rings and a fraction of the arc assemblies pierced the membrane.
We cannot discard the presence of smaller Bax assemblies associated with
pores that are below the resolution limit inherent to the techniques. This
is around 20 nm for SMLM and between 20 to 45 nm for AFM under our
specific experimental conditions (nominal tip radius of 20 nm). These results
demonstrate that lipids directly participate in the pore architectures formed
by Bax and that the protein molecules can partially or totally outline the
pore edge.
To our knowledge, this is also the first direct evidence that Bax oligomers
delineate membrane pores. Furthermore, these findings strongly suggest
that the Bax structures identified at mitochondria are directly involved in
MOM permeabilization via direct pore formation.
Recently, another 3D super-resolution study revealed that Bax rings are
empty of fluorescent mitochondrial markers, also supporting the model
of Bax pore formation (Große et al., 2016). Bax rings were detected in
mitochondrial regions where cyt c was not yet released, suggesting that cyt
c release needs additional steps besides Bax pore formation. It is likely
that the overall mitochondrial reorganization happening during apoptosis
includes important processes for this release (Scorrano et al., 2002; Prudent
et al., 2015; Große et al., 2016).
Previous in vitro studies with cryo_EM reported the opening of pores
induced by Bax on purified MOMs (Gillies et al., 2015). The transmission
EM data on mammalian cells shown in this work provide the first evidence
for the existence of these pores in the mitochondria of apoptotic cells. As
the mitochondria of healthy cells appeared intact, these results support the
role of the GFP-Bax assemblies identified here in the formation of pores at
the MOM of apoptotic cells.
Bax arrangements were characterized by a wide distribution of shapes and
sizes, which argues in favor of a non-uniform organization of Bax oligomers
at the MOM. In agreement with our findings, Bax pores ranging from 3.5
to several hundreds of nanometers (Xu et al., 2013; Bleicken et al., 2010)
as well as multiple types of Bax aggregates (Annis et al., 2005; Tan et al.,
1999; Antonsson, 2001) have been previously described. This heterogeneity
is in contrast with the results obtained for the nuclear pore (Szymborska
et al., 2013) or for other pore-forming proteins (Metkar et al., 2015; Sonnen
et al., 2014), which revealed highly homogeneous structures, and precluded
further modeling of the Bax pore structure by averaging approaches.
Altogether, our structural data support a model by which Bax assembles
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into a flexible toroidal pore structure able to change in size depending on Bax
density in the membrane (Bleicken et al., 2013). This model would explain
the different sizes of the pores and oligomers formed by Bax (Bleicken et al.,
2013; Fuertes et al., 2010; Kuwana et al., 2002) without discarding that
additional proteins like Bak or other unknown factors, not detected here,
could also be forming part of the pore structure.
Most of the Bax signal detected with SMLM corresponded to random,
undefined clusters, from which no specific molecular organization could be
distinguished. This could be related to partial labeling with the nanobodies,
insufficient spatial resolution due to out of focus effects, orientation of
the structure with respect to the observation plane, or simply no supra-
organization of a fraction of Bax oligomers at the nanometer scale. Along
these lines of reasoning, it is important to consider that the variety of defined
Bax structures including lines, arcs and rings, could correspond to the same
type of supramolecular organization observed from different angles or with
different degrees of assembly.
On the one hand, in the case of complete rings and arcs, only those which
are observed perpendicular to the ring/arc plane would be detected as such in
the two dimensional SMLM approach used here, while any other orientation
would likely appear as a line, or less likely due to off-focus blurring, as
an ellipse. Within the cell, the tubules of the mitochondrial network can
adopt all possible orientations, where the longer tubes have a preference
for those orientations best adapting to the cellular shape. As a result, it is
unlikely that most of Bax rings and arcs would be detected and classified as
such, which is in agreement with the lower frequency of these structures in
comparison with lines. Besides, the length of lines and arcs is in the same
range as the diameter of the full rings, taking into account the variations in
the size of the different structures observed, which would also support this
possibility.
On the other hand, lines, arcs, and rings could represent different stages in
the assembly of nascent evolving Bax pores. In this scenario, Bax molecules
would first organize into linear and arc-shaped structures and some of them
would evolve into complete rings. It could also be that lines and arcs
correspond to kinetically trapped intermediates in the process of full ring
assembly. Interestingly, the AFM data in supported bilayers, where both
rings and arc-shaped assemblies of Bax coexist with the same orientation
with respect to the membrane plane and are involved in pore formation,
demonstrate the existence of lines, arcs, and rings as distinct structures of
Bax oligomers. Nevertheless, both situations are not mutually exclusive,
and it is conceivable that the structures detected in apoptotic mitochondria
correspond to a mixture of different assembly stages observed from different
orientations.
Our finding that not only full rings but also arc-shaped Bax assemblies
form membrane pores has unanticipated implications for the molecular
mechanism how Bax permeabilizes the MOM in apoptosis (Fig. 10.1a).
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Stabilization of toroidal pores requires a decrease in the line tension
associated with the extremely high membrane curvature generated at the
pore edge (Karatekin et al., 2003). In agreement with this, a peptide derived
from helix 5 of Bax, which reproduces the pore activity of the full-length
protein, is able to reduce line tension at interfaces with high curvature
stress (García-Sáez et al., 2005, 2007). In this scenario, both full and partial
coverage of the pore boundary by protein molecules could provide enough
line tension reduction to stabilize the open pore state.
Recent studies with pore-forming toxins of the membrane attack complex
perforin cholesterol-dependent cytolysin superfamily, which also form toroidal
pores but based on β-structural elements, report the involvement of both
complete rings as well as arc-shaped oligomeric assemblies in pore formation
(Gilbert et al., 2014; Leung et al., 2014; Metkar et al., 2015; Sonnen et al.,
2014; Stewart et al., 2015). Incomplete coverage of the pore rim has also
been observed for Bax monomers in lipid nanodiscs (Xu et al., 2013).
Based on this, we propose that the physical-chemical principle by which
Bax stabilizes membrane pores is not by building a poly-peptide wall that
buries the hydrophobic membrane core, but rather by releasing the curvature
stress at the membrane edge (Ros and García-Sáez, 2015). The set of archi-
tectures of Bax oligomers in apoptotic mitochondria and their relationship
to pore formation demonstrated here support a new molecular mechanism
of Bax during apoptosis (Fig. 10.1a).
Upon activation, Bax would accumulate in mitochondria, where it would
undergo a conformational change accompanied by extensive membrane
insertion (Annis et al., 2005; García-Sáez et al., 2004). Bax molecules would
then stably associate via their dimerization domain (Aluvila et al., 2014;
Bleicken et al., 2010, 2014; Czabotar et al., 2013; Dewson et al., 2008, 2012;
Subburaj et al., 2015; Zhang et al., 2010) and continue to self-assemble into
larger oligomers, which might contain Bak or other MOM proteins (Zhou
and Chang, 2008). These oligomers would initially organize as linear and
arc-shaped structures, some of which would induce the opening of MOM
pores responsible for the release of the apoptotic factors. In order to stabilize
these pores, Bax oligomers would partially delineate the pore edge in a
“clamp” conformation (Bleicken et al., 2014) (Fig. 10.1b). Incorporation of
additional Bax molecules into the pore structures would then lead to the
formation of full Bax rings and to pore growth.
In summary, this work reports the supramolecular organization of Bax
oligomers at mitochondria of apoptotic cells with unprecedented detail
and the ability of ring and arc-shaped Bax assemblies to perforate lipid
membranes.
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10.2. Interplay between mitochondrial
permeabilization and fission
Mitochondria undergo massive fragmentation under apoptotic conditions,
which happens close in time with Bax-mediated MOM permeabilization
(Brooks et al., 2011). Active Bax accumulates at specific sites on the MOM
where fragmentation has happened or is about to happen, colocalizing with
Drp1 (Karbowski et al., 2002). Drp1 is a dynamin-like GTPase that has
been proposed to mediate mitochondrial fragmentation via the formation
of constrictive tubular or spiral-like scaffolds around the mitochondrial
perimeter.
Despite achieving a lower resolution for Drp1 due to the lower performance
of the dye cf680 compared to alexa647, we found some non-random structures,
mainly shaped as lines, which would agree with the formation of one ring
around mitochondria and are comparable to those reported in a recent
superresolution study of Drp1 (Rosenbloom et al., 2014). The identification
of few GFP-Bax double-line assemblies would also support the possibility
that in some cases two Drp1 rings could wrap mitochondria. Remarkably,
a similar organization has been proposed for dynamin during vesicle neck
scission (Chen et al., 2004).
We also found that active Bax and Drp1 assemblies are very close to
each other, in the order of a few tens of nanometers, and have a similar
shape and size. This provides a structural basis for the functional interplay
between these two proteins. It is tempting to speculate that the Drp1 scaffold
could contribute to the supra-molecular organization of Bax at the MOM.
Bax oligomers could assemble as full or incomplete rings along the Drp1
assemblies, thus wrapping mitochondria. The different lengths measured
for Bax linear assemblies fit well to the diameter of healthy or constricted
mitochondria, respectively. On the other hand, the reported diameter for
constricted mitochondria and the size of Drp1 helices is approximately 100-
150 nm in yeast and in vitro (Ingerman et al., 2005; Mears et al., 2011;
Friedman et al., 2011), which is comparable to the length of the shorter
population of lines. A similar hypothesis can be applied to the two well-
defined populations of arcs, which could accommodate well either in the
constriction sites or at the mitochondrial tips. In that case, Bax would be
able to collaborate with Drp1 to promote MOM permeabilization and/or
mitochondrial fragmentation.
Along these lines, Drp1 deficient cells, besides presenting elongated mito-
chondria also show delayed cyt c release in apoptosis (Große et al., 2016).
Moreover, the Drp1 adaptors MiD49/51 play an active role in cristae re-
modeling during intrinsic apoptosis, a requisite for cytochrome c release
(Otera et al., 2016). In contrast to some reports in the literature arguing
that inhibition of mitochondrial fission or Drp1 knock-out can lead to little
or partial resistance to apoptosis (Wakabayashi et al., 2009; Ishihara et al.,
2003), growing evidence supports a direct role of the fission machinery in
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mitochondrial permeabilization, and, consequently, in apoptosis regulation.
Our findings shed light on the nature of this interplay. Besides the close
proximity between Drp1 and Bax in apoptotic cells, here we found direct
complex formation between the two proteins in lipid membranes at the
single molecule level. The lack of interaction in solution suggests that the
membrane environment is needed for Bax and Drp1 interplay, consistent with
the active role of the membrane proposed for the activation and function of
Bcl-2 proteins (García-Sáez et al., 2009; Llambi et al., 2011; Lovell et al.,
2008; Bleicken et al., 2013).
In order to achieve Bax binding to the GUVs and to investigate Bax
and Drp1 interaction at the vesicle level, we needed to activate the protein
by mild heat. This indicates that Drp1 alone is not sufficient to activate
Bax, contrary to cBid. This is in agreement with previous observations by
Montessuit et al. showing that Drp1 could only enhance Bax oligomerization
once it was already activated by cBid (Montessuit et al., 2010).
Moreover, cBid decreased the cross-correlation between Drp1 and Bax
on membranes, suggesting that it can compete for such interactions. It is
known that cBid binding to membranes induces Bax oligomerization and
activation (Bleicken et al., 2013). In this scenario, one possibility for Drp1-
Bax complex disruption by cBid could be the competition of cBid and Drp1
for the same binding site in Bax. However, we cannot discard that cBid
induces a conformation of Bax that is not able to interact with Drp1.
Mechanistically, Drp1 likely induces membrane hemifusion intermediates
at sites enriched with cardiolipin, a lipid specific of mitochondria and with
intrinsic monolayer curvature. Drp1 binding to GUVs also promotes tubu-
lation and vesicle tethering, as part of its membrane remodeling function
(Montessuit et al., 2010; Ugarte-Uribe et al., 2014; Stepanyants et al., 2015;
Bleicken et al., 2016). In this work, we could reproduce Drp1-induced tubu-
lation and vesicle tethering in free standing bilayers, using Drp1 protein
purified without any tag.
Besides promoting tBid-induced Bax oligomerization (Montessuit et al.,
2010), such Drp1-induced non-bilayer structures could contribute to Bax-
induced MOM permeabilization by lowering the energy required for toroidal
pore formation and stabilization. On these grounds, Bax and cBid induce
membrane budding and vesicle tethering, and they both bind predominantly
to the highly curved membranes at the neck of the bud (Bleicken et al.,
2016), which strongly supports our hypothesis. Indeed, we observed that
heat-activated Bax also binds to this specific lipidic regions in presence of
Drp1. The likely preference for Bax to form pores at those sites could also
play a role on its non-random localization along the mitochondria due to
the restricted amount of those intermediates along the membrane.
Moreover, mitochondrial fragmentation involves a process of membrane
fission, for which the opening of a pore has been proposed to be a struc-
tural intermediate (Kozlovsky and Kozlov, 2003). The stabilization of pore
structures by Bax at the mitochondrial fission sites could also contribute to
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lowering the energy for membrane fission and to Drp1-mediated mitochon-
drial fragmentation.
Bcl-xL has an opposing role to Bax in apoposis. In addition to inhibiting
cBid/Bax pore formation, it hinders vesicle budding and fusion (Bleicken
et al., 2016). Bax inhibition by Bcl-xL can happen at different levels: (1)
via tBid binding to block Bax activation by this protein (García-Sáez et al.,
2009; Bleicken et al., 2013), (2) by disrupting Bax homo-oligomers at the
membrane (Subburaj et al., 2015), (3) by re-translocating Bax from the
MOM to the cytosol (Todt et al., 2013; Edlich et al., 2011), and (4) by
impairing its effect on stabilizing curved membranes (Bleicken et al., 2016).
On the other hand, membrane remodeling by Drp1 contributes to Bax
oligomerization, so it is not trivial to think that Bcl-xL could localize at the
same mitochondrial foci as Bax and Drp1 during mitochondrial fragmen-
tation and contribute to Bax inhibition also by affecting Drp1 remodeling
function. The interaction between of Bcl-xL and Drp1 in GUVs detected here
pinpoints a direct association between this two proteins at the membrane
level. Interestingly and similarly to Bax, Bcl-xL concentrated in highly
curved vesicle regions, and cBid was also able to decrease Drp1-Bcl-xL
interactions. Taking this into account, one could argue for a similar scenario
of cBid inhibition as the one speculated for Bax. However, unlike Bax,
Bcl-xL is also able to form complexes with Drp1 in solution. This could
represent an additional mechanism for Bax inhibition by Bcl-xL, through
the impairment of Drp1 contribution to Bax oligomerization. As Bcl-xL has
already been shown to stimulate Drp1 GTPase activity (Li et al., 2008), our
data also provide a step further in the understanding of Bcl-xL impact on
mitochondrial fusion and fission. However, more research is still necessary
before obtaining a definitive answer to the functional implications of Drp1
in Bcl-2 family regulation.
In conclusion, the close proximity to Drp1 scaffolds suggests that Bax ring
and arc-shaped assemblies could contribute to the massive mitochondrial
fragmentation during apoptosis. Altogether, our results shed new light on
the cellular mechanism of apoptosis induction by Bax and pave the way for
further characterization of the pore structures formed at the MOM during
apoptosis. In addition, the data presented here support a mechanistic link
between MOMP and mitochondrial dynamics.
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The conclusions that can be drawn from this thesis are the following:
1. Bax assembles into non-random structures in mammalian cells, includ-
ing complete rings, arcs, and lines which are related to the functional
role of Bax in MOM permeabilization during apoptosis.
2. Rings and arc-shaped assemblies of Bax are able to perforate lipid
membranes, providing a link of theses structures with Bax function.
3. Drp1 and Bax localize very close to each other if not completely
colocalizing at discrete foci on apoptotic mitochondria.
4. Drp1 and Bax interact in vitro in lipid membranes, but not in the 3D
solution. This interaction can be disrupted by cBid.
5. Drp1 is also able to form a complex with Bcl-xL both in membranes
and in solution. cBid also can interfere in the complex at the membrane
level.
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